{"service":"scrimed-commercial-growth-engine","route":"/growth-engine","apiRoute":"/api/growth-engine","briefRoute":"/api/growth-engine/brief","status":"commercial-growth-engine-active","briefStatus":"commercial-growth-engine-brief-ready-no-revenue-guarantee","boundary":"SCRIMED Commercial Growth Engine organizes buyer segments, sellable offers, revenue motions, proof routes, conversion actions, bottlenecks, and retained approval gates for synthetic evaluations, readiness assessments, and protected enterprise pilots. It is growth execution readiness only. It is not a customer revenue guarantee, investment advice, securities offering material, audited financial reporting, valuation assurance, legal advice, tax advice, reimbursement assurance, procurement approval, customer permission, security certification, regulatory approval, PHI processing approval, production connector approval, or live clinical care authorization.","growthPlayCount":6,"executeNowPlayCount":2,"packageNextPlayCount":2,"protectedGatedPlayCount":1,"externalReviewPlayCount":1,"conversionLaneCount":4,"proofLadderStepCount":5,"growthBottleneckCount":4,"operatorRequiredBottleneckCount":1,"protectedGatedBottleneckCount":1,"externalReviewBottleneckCount":1,"proofRouteCount":25,"allProofRoutes":["/pricing","/product","/demos","/pilot","/sales-operations","/capital-vitality","/pilots","/pilot-deal-room","/evaluation","/approvals-readiness","/boundary-resolution","/qa-claim-guard","/trust-center","/buyer-release-control-run","/pilot-workspace/access","/global-reach","/deployment-profiles","/market-activation","/public-market-readiness","/workflows/results","/atlas","/growth-engine","/healthcare-intelligence-os","/qa-evidence","/clinical-authority-readiness"],"sourceCounts":{"pricingTierCount":6,"salesMotionStepCount":5,"valueMetricCount":5,"revenueStreamCount":5,"targetAudienceCount":8,"capitalRevenueCapabilityCount":8,"moatSignalCount":9,"investorMilestoneCount":8,"fundingWorkstreamCount":8,"publicMarketMetricCount":10,"publicMarketCustomerProofStageCount":5,"dealRoomStageCount":6},"authority":{"dataBoundary":"synthetic-only","revenueAuthority":"not-revenue-guarantee","investmentAdvice":"not-investment-advice","securitiesAuthority":"not-securities-offering-material","financialAuthority":"not-audited-financial-report","valuationAuthority":"not-valuation-assurance","approvalAuthority":"external-review-required","phiAuthority":"not-authorized-production-phi","clinicalCareAuthority":"not-authorized-live-care","securityCertification":"not-security-certified"},"nextGrowthMove":"Run founder-led assessment and synthetic-pilot outreach from /growth-engine, attach each conversation to one proof route, keep buyer-specific evidence protected, and route revenue, securities, legal, tax, valuation, reimbursement, PHI, security, connector, and live-care claims through retained external gates.","growthPlays":[{"name":"Founder-led assessment sprint","status":"execute-now","buyerSegment":"Health system operations, access, documentation, transformation, and revenue-cycle leaders","primaryOffer":"Workflow Intelligence Assessment","revenueMotion":"Convert warm executive conversations into paid fixed-scope assessments with one to three workflow targets.","commercialEvidence":"Pricing, market activation, product console, demos, pilot intake, and sales operations already support this motion.","proofRoutes":["/pricing","/product","/demos","/pilot","/sales-operations"],"owner":"Founder + enterprise sales","blockedBoundary":"No PHI, no live clinical execution, no savings guarantee, and no medical advice.","nextAction":"Run a weekly sponsor list, route qualified buyers to Pilot Intake, and package each call around one workflow pain plus one proof route."},{"name":"Synthetic Atlas pilot pipeline","status":"execute-now","buyerSegment":"Enterprise sponsors ready to test governed workflow intelligence before integration","primaryOffer":"Synthetic Pilot Evaluation","revenueMotion":"Move qualified assessment or demo interest into a 45 to 90 day synthetic pilot with success metrics and proof packets.","commercialEvidence":"Capital Vitality, Pilot Programs, Pilot Deal Room, and AgentOS evaluation make the synthetic pilot inspectable.","proofRoutes":["/capital-vitality","/pilots","/pilot-deal-room","/evaluation"],"owner":"Founder + sales engineering","blockedBoundary":"Synthetic-only evidence until buyer-specific approvals, security review, and governance gates are retained.","nextAction":"Use the Deal Room to frame pilot scope, review team, synthetic packet, decision metric, and protected workspace path."},{"name":"AI governance audit wedge","status":"package-next","buyerSegment":"Compliance, legal, privacy, security, clinical governance, and innovation leaders","primaryOffer":"AI Readiness + Governance Audit","revenueMotion":"Sell governance readiness as a paid entry point for teams under pressure to control healthcare AI adoption.","commercialEvidence":"Approvals Readiness, Boundary Resolution, Claim Guard, Trust Center, and Service Reliability show operating discipline.","proofRoutes":["/approvals-readiness","/boundary-resolution","/qa-claim-guard","/trust-center"],"owner":"Founder + trust operations","blockedBoundary":"Readiness audit is not HIPAA certification, SOC 2 certification, HITRUST certification, legal approval, or FDA clearance.","nextAction":"Create counsel-reviewable sales language and keep every certification or regulatory phrase behind external-review gates."},{"name":"Protected buyer diligence upgrade","status":"protected-gated","buyerSegment":"Procurement, security, investor diligence, and executive buying committees","primaryOffer":"Protected Buyer Diligence Room","revenueMotion":"Attach paid diligence packaging to enterprise pilot pursuits once buyer-specific evidence needs are known.","commercialEvidence":"Buyer Release Control Runbook, protected workspace, evidence-room routing, and distribution lockbox readiness exist.","proofRoutes":["/buyer-release-control-run","/pilot-workspace/access","/pilot-deal-room"],"owner":"Buyer diligence + release steward","blockedBoundary":"External sharing stays blocked until release decisions, reviewer signoffs, recipient controls, access logs, and customer permission are retained.","nextAction":"Keep diligence packaging metadata-only until buyer-approved storage, access review, DLP, retention, and legal hold controls exist."},{"name":"Public-sector and global partner program","status":"external-review-required","buyerSegment":"Government health systems, sovereign programs, public-sector buyers, and qualified channel partners","primaryOffer":"Strategic Platform Partnership","revenueMotion":"Use global buyer packs and deployment profiles to scope strategic programs before procurement or regional claims expand.","commercialEvidence":"Global Reach, Deployment Profiles, Market Activation, and Public Market Readiness encode the strategic partnership path.","proofRoutes":["/global-reach","/deployment-profiles","/market-activation","/public-market-readiness"],"owner":"Founder + strategic partnerships + qualified reviewers","blockedBoundary":"No regional legal approval, public-sector procurement approval, data-residency approval, or government endorsement claim.","nextAction":"Pair every regional or public-sector conversation with qualified legal, privacy, security, procurement, and deployment review."},{"name":"Revenue-cycle proof wedge","status":"package-next","buyerSegment":"Payer, provider, and revenue-cycle leaders with denial, authorization, and documentation friction","primaryOffer":"Revenue workflow synthetic pilot","revenueMotion":"Position denial-risk, missing-evidence, and policy-friction workflows as measurable synthetic pilots before buyer data exposure.","commercialEvidence":"Public Market KPI definitions, workflow result packets, pricing value metrics, and Atlas evidence routes support the wedge.","proofRoutes":["/public-market-readiness","/workflows/results","/pricing","/atlas"],"owner":"Founder + product + sales engineering","blockedBoundary":"No final billing action, no payer submission, no reimbursement guarantee, and no audited financial impact claim.","nextAction":"Package a no-PHI demonstration around one denial or prior-authorization support workflow and one buyer-approved value metric."}],"conversionLanes":[{"source":"Founder network and direct executive outreach","buyerTrigger":"Visible operational pain, AI governance pressure, or transformation mandate","entryRoute":"/product","proofRoute":"/pilot-deal-room","conversionEvent":"Pilot Intake submitted with named sponsor and workflow scope","followUp":"Route to Sales Operations and schedule assessment or synthetic-pilot scoping.","disqualifiers":["Requires PHI in first call","Wants autonomous clinical decisions","No executive or operational sponsor"]},{"source":"Product-led proof review","buyerTrigger":"Buyer inspects demos, pricing, Trust Center, and proof routes before contacting SCRIMED","entryRoute":"/demos","proofRoute":"/pricing","conversionEvent":"Buyer asks for pilot pricing, workflow evidence, or governance packet","followUp":"Send assessment/pilot framing with no-PHI boundary and buyer-specific questions.","disqualifiers":["Requests unsupported compliance claims","Needs immediate production connector"]},{"source":"Governance and security review","buyerTrigger":"AI risk, vendor diligence, BAA/DPA planning, claims control, or board scrutiny","entryRoute":"/trust-center","proofRoute":"/approvals-readiness","conversionEvent":"Buyer asks for governance audit, evidence room, or protected pilot controls","followUp":"Offer AI Readiness + Governance Audit and map required external-review domains.","disqualifiers":["Wants certification without external audit","Rejects human-review or no-PHI boundaries"]},{"source":"Investor, board, and advisor diligence","buyerTrigger":"Category, moat, unit economics, customer proof, or growth strategy review","entryRoute":"/capital-vitality","proofRoute":"/growth-engine","conversionEvent":"Reviewer asks for operating cadence, proof ladder, or commercial priorities","followUp":"Share readiness-only brief and route securities, valuation, legal, or tax questions to qualified advisors.","disqualifiers":["Requests investment advice","Requests fundraising materials without counsel review"]}],"revenueProofLadder":[{"stage":"Public proof","commercialQuestion":"Can the buyer understand what SCRIMED is and why it is different?","answer":"Use Product Console, Healthcare Intelligence OS, demos, Trust Center, and Capital Vitality.","metric":"Qualified buyer moves to intake or executive review.","proofRoutes":["/product","/healthcare-intelligence-os","/demos","/trust-center","/capital-vitality"],"status":"ready","retainedGate":"No public customer, clinical, revenue, securities, or certification overclaim."},{"stage":"Paid assessment","commercialQuestion":"Can SCRIMED sell a bounded first engagement without live data exposure?","answer":"Use Workflow Intelligence Assessment with no-PHI scope, buyer baseline questions, and governance review.","metric":"Assessment sponsor, workflow scope, and decision criteria retained.","proofRoutes":["/pricing","/pilot","/sales-operations"],"status":"ready","retainedGate":"No PHI, no medical advice, no guaranteed savings."},{"stage":"Synthetic pilot","commercialQuestion":"Can SCRIMED prove workflow value through governed synthetic evidence?","answer":"Use Synthetic Atlas Pilot, AgentOS evaluation, workflow results, QA proof, and Deal Room packaging.","metric":"Synthetic work packet complete with reviewable outcome, Trust Card, and buyer decision route.","proofRoutes":["/pilots","/evaluation","/workflows/results","/qa-evidence","/pilot-deal-room"],"status":"measurement-required","retainedGate":"Buyer-approved metrics before external value claims."},{"stage":"Protected enterprise pilot","commercialQuestion":"Can the buyer safely move from synthetic proof into controlled protected evaluation?","answer":"Use protected workspace, release-control chain, authority readiness, provider security review, and procurement evidence routing.","metric":"Protected workspace and no-PHI packet controls active with retained AAL2 operator proof.","proofRoutes":["/pilot-workspace/access","/buyer-release-control-run","/clinical-authority-readiness"],"status":"protected-gated","retainedGate":"AAL2, external approvals, buyer permission, legal/privacy/security gates, and no-PHI evidence rules."},{"stage":"Enterprise license","commercialQuestion":"Can SCRIMED expand into annual operating value after protected validation?","answer":"Use deployment profiles, public-market KPI discipline, finance methodology gates, and board scorecards.","metric":"Buyer-approved operating value, security posture, implementation scope, and license owner.","proofRoutes":["/deployment-profiles","/public-market-readiness","/pilot-workspace/access"],"status":"external-review-required","retainedGate":"Customer contracts, security review, legal approval, connector approval, and production authority."}],"growthBottlenecks":[{"name":"Founder-led selling is still the fastest path","status":"operator-required","impact":"SCRIMED has proof depth, but early enterprise conversion still needs direct founder narrative and qualification.","workaround":"Run weekly target-account review, use Pilot Intake for every qualified call, and keep proof routes attached to each follow-up.","graduationGate":"Repeatable source-to-pilot conversion cohorts in Attribution Analytics.","owner":"Founder + sales operations"},{"name":"Buyer proof cannot outrun retained approvals","status":"protected-gated","impact":"The strongest enterprise proof is protected and cannot be shared publicly without release controls.","workaround":"Use metadata-only public summaries and route buyer-specific artifacts through protected release-control and distribution lockbox gates.","graduationGate":"Release decisions, reviewer signoffs, recipient controls, and customer permission retained.","owner":"Release steward + buyer diligence"},{"name":"Revenue impact claims require buyer baselines","status":"contained","impact":"Revenue-cycle value is compelling, but unsupported revenue claims can create legal, reimbursement, or investor risk.","workaround":"Frame revenue impact as buyer-reviewed operational signal until protected buyer methodology and finance review exist.","graduationGate":"Buyer-approved baseline, finance methodology gate, and counsel-reviewed external-use language.","owner":"Founder + finance reviewers"},{"name":"Fundraising and investor materials need counsel review","status":"external-review-required","impact":"Capital readiness can be mistaken for offering material or investment advice.","workaround":"Keep public routes readiness-only and route fundraising decks, valuation, securities language, tax, and legal questions through qualified counsel.","graduationGate":"Approved investor materials, controlled data-room process, and qualified securities counsel review.","owner":"Founder + qualified counsel"}],"capitalVitalitySummary":{"service":"scrimed-capital-vitality","route":"/capital-vitality","apiRoute":"/api/capital-vitality","briefRoute":"/api/capital-vitality/brief","status":"capital-vitality-revenue-funding-readiness-active","briefStatus":"capital-vitality-brief-ready-no-securities-offer","fundingVitalityPosture":"investor-ready-readiness-materials-no-securities-offer","boundary":"SCRIMED Capital Vitality organizes revenue capabilities, competitive moat evidence, investor-readiness milestones, funding workstreams, and retained external-review gates. It strengthens commercial execution and diligence readiness, but it is not investment advice, securities offering material, audited financial reporting, valuation assurance, legal advice, tax advice, reimbursement assurance, customer revenue guarantee, security certification, regulatory approval, PHI processing approval, production connector approval, or live clinical care authorization.","authority":{"dataBoundary":"synthetic-only","financialAuthority":"not-audited-financial-report","securitiesAuthority":"not-securities-offering-material","investmentAdvice":"not-investment-advice","valuationAuthority":"not-valuation-assurance","reimbursementAuthority":"no-reimbursement-guarantee","approvalAuthority":"external-review-required","clinicalCareAuthority":"not-authorized-live-care","phiAuthority":"not-authorized-production-phi","securityCertification":"not-security-certified"},"sourceAlignment":{"pageRouteCount":164,"apiRoutePatternCount":439,"smokeCoveredHtmlRouteCount":76,"commercialPricingStatus":"pricing-and-sales-motion-ready","marketActivationStatus":"revenue-message-comms-foundation-ready","publicMarketReadinessStatus":"capital-efficiency-kpi-stack-ready","salesDealRoomStatus":"public-organization-and-protected-packet-ready","serviceReliabilityStatus":"service-reliability-hardening-active"},"revenueCapabilityCount":8,"activeRevenueCapabilityCount":2,"packagedRevenueCapabilityCount":3,"protectedGatedRevenueCapabilityCount":2,"externalReviewRevenueCapabilityCount":1,"moatSignalCount":9,"highMoatSignalCount":4,"investorMilestoneCount":8,"readyInvestorMilestoneCount":4,"externalReviewMilestoneCount":2,"operatorRequiredMilestoneCount":1,"fundingWorkstreamCount":8,"activeFundingWorkstreamCount":3,"externalReviewWorkstreamCount":3,"retainedExternalReviewCount":5,"proofRouteCount":51,"revenueCapabilities":[{"name":"Synthetic Atlas Pilot","buyer":"Health systems, payers, public-sector health teams, and enterprise innovation sponsors","status":"packaged","revenueMotion":"30 to 90 day governed synthetic pilot with executive findings and production-readiness gates.","priceLogic":"Packaged as a premium fixed-fee pilot before any protected enterprise or production-license commitment.","proofRoutes":["/product","/pilot-deal-room","/pilots","/pricing"],"limitation":"Pilot evidence remains synthetic or protected-evaluation only until buyer-specific live controls are approved.","nextAction":"Use the Deal Room and Pilot Intake to qualify sponsor, workflow scope, review team, and success metrics."},{"name":"Workflow Intelligence Assessment","buyer":"Clinical operations, access, revenue cycle, documentation, and transformation leaders","status":"active","revenueMotion":"Short paid assessment that maps workflow friction, AI readiness, governance gaps, and pilot candidates.","priceLogic":"Fixed-scope assessment with clear upgrade path into Synthetic Atlas Pilot.","proofRoutes":["/pricing","/product","/pilot","/sales-operations"],"limitation":"Findings are operational intelligence for human leaders, not medical, legal, reimbursement, or accounting advice.","nextAction":"Keep assessment outputs tied to proof routes, governance gates, and buyer-approved baselines."},{"name":"AI Readiness + Governance Audit","buyer":"Compliance, security, legal, clinical governance, innovation, and executive sponsors","status":"packaged","revenueMotion":"Readiness engagement for claims control, privacy posture, auditability, role controls, runtime safety, and approval gates.","priceLogic":"Assessment fee that can expand into protected pilot controls and enterprise diligence work.","proofRoutes":["/approvals-readiness","/boundary-resolution","/clinical-authority-readiness","/trust-center"],"limitation":"Readiness audit does not certify HIPAA, SOC 2, HITRUST, FDA, ONC, security posture, or legal compliance.","nextAction":"Route any certification, regulatory, or legal claim through qualified external reviewers."},{"name":"Clinical Operations Automation Blueprint","buyer":"Hospitals, clinics, payers, and public-sector health programs planning phased automation","status":"packaged","revenueMotion":"Blueprint package for agent responsibilities, connector plan, review queues, safety controls, and staged deployment path.","priceLogic":"Strategy and implementation-planning package that precedes protected pilot or enterprise license.","proofRoutes":["/agents","/workflows","/healthcare-intelligence-os","/interoperability"],"limitation":"Blueprint remains review-only and does not authorize live clinical workflow execution or production connectors.","nextAction":"Translate each automation candidate into blocked actions, human checkpoints, and audit evidence."},{"name":"Protected Buyer Diligence Rooms","buyer":"Enterprise buyers, procurement, security reviewers, investor diligence teams, and executive sponsors","status":"protected-gated","revenueMotion":"Paid buyer-specific diligence packaging with proof packets, release controls, and metadata-only evidence routing.","priceLogic":"Bundled into enterprise pilot/procurement motion; future premium service when release authority is retained.","proofRoutes":["/pilot-workspace/access","/buyer-release-control-run","/pilot-deal-room"],"limitation":"External sharing remains blocked until release decisions, reviewer signoffs, recipient controls, and access-log reconciliation are retained.","nextAction":"Complete the protected release-control chain before any buyer-specific external distribution."},{"name":"TrustOps Incident And Claims Control","buyer":"Enterprise risk, legal, security, marketing, buyer diligence, and operator teams","status":"active","revenueMotion":"Trust, safety, claims, and incident-readiness support for enterprise AI operations and buyer confidence.","priceLogic":"Packaged as governance support attached to pilots and enterprise readiness work.","proofRoutes":["/trust-safety-operations","/qa-claim-guard","/claims","/trust-center"],"limitation":"Operating model does not create managed 24/7 coverage, legal approval, public-claim approval, or certification by itself.","nextAction":"Keep buyer, investor, PR, advertising, and operator claims routed through Claim Guard before publication."},{"name":"Deployment Profile Advisory","buyer":"Security-sensitive hospitals, governments, sovereign programs, and infrastructure partners","status":"external-review-required","revenueMotion":"Advisory package for managed cloud, private cloud, hospital-controlled, sovereign, and edge deployment readiness.","priceLogic":"Premium planning motion that can expand into strategic platform partnership after legal/security review.","proofRoutes":["/deployment-profiles","/global-reach","/market-activation","/interoperability"],"limitation":"Deployment profiles do not grant regional approval, data-residency approval, security certification, or procurement acceptance.","nextAction":"Attach qualified regional legal, privacy, security, and procurement review before external claims expand."},{"name":"Interoperability Conformance Readiness","buyer":"IT, interoperability, EHR, payer, research, and device-integration reviewers","status":"protected-gated","revenueMotion":"Conformance-readiness engagement around standards mapping, fixtures, synthetic tests, and live connector prerequisites.","priceLogic":"Technical diligence package that supports pilots and future implementation scope.","proofRoutes":["/interoperability","/interoperability/evaluations","/integrations","/synthetic/validation"],"limitation":"Synthetic conformance evidence is not live connector certification, trading-partner acceptance, or production data exchange authority.","nextAction":"Keep live connector claims blocked until buyer, legal, security, privacy, and partner approvals exist."}],"competitiveMoatSignals":[{"name":"Healthcare Intelligence OS category position","strength":"high","evidence":"SCRIMED combines AgentOS, Atlas Intelligence Core, TrustOS, workflows, interoperability, and buyer diligence into one healthcare operations layer.","proofRoutes":["/healthcare-intelligence-os","/product","/agents","/atlas"],"defendability":"The moat is domain workflow orchestration plus trust evidence, not general model access.","retainedBoundary":"Architecture proof is not production authorization or clinical validation."},{"name":"TrustOS and Claim Guard discipline","strength":"high","evidence":"Policy evaluation, claim control, blocked authority language, and no-authority headers are embedded across high-risk routes.","proofRoutes":["/trust-os","/qa-claim-guard","/claims","/api/product/console"],"defendability":"Healthcare buyers need governed explainability, boundaries, and audit posture before automation scale.","retainedBoundary":"Trust controls are readiness evidence, not legal advice or compliance certification."},{"name":"Atlas evidence and Trust Cards","strength":"high","evidence":"Evidence routes, Trust Cards, source intelligence, and workflow result packets create inspectable support for buyer review.","proofRoutes":["/atlas","/trust","/source-intelligence","/workflows/results"],"defendability":"Evidence-backed workflow outputs are harder to copy than a model wrapper.","retainedBoundary":"Evidence organization does not guarantee clinical outcome, reimbursement, or customer revenue."},{"name":"Protected buyer release-control chain","strength":"high","evidence":"Buyer release decisions, reviewer signoffs, disabled distribution lockbox controls, recipient controls, and access-log reconciliation are staged before external sharing.","proofRoutes":["/buyer-release-control-run","/pilot-workspace/access","/qa-buyer-proof-release"],"defendability":"Enterprise diligence friction becomes a managed product capability.","retainedBoundary":"Release-control readiness is not release approval or customer permission."},{"name":"Service Reliability fault/control map","strength":"medium","evidence":"Product/service controls, fault classes, efficiency improvements, open gates, and owners are inspectable before claims expand.","proofRoutes":["/service-reliability","/navigation","/release-continuity"],"defendability":"Operational maturity compounds as every new surface inherits route, smoke, and boundary checks.","retainedBoundary":"Reliability hardening is not security certification or approval authority."},{"name":"Public route and smoke discipline","strength":"medium","evidence":"Navigation Audit ties page inventory, API pattern count, route groups, smoke coverage, and protected fail-closed behavior together.","proofRoutes":["/navigation","/api/navigation-audit","/api/navigation-audit/brief"],"defendability":"Route-count controls reduce drift as the product surface grows.","retainedBoundary":"Route control does not prove protected happy-path execution."},{"name":"Public Market KPI and protected board metric ladder","strength":"medium","evidence":"KPI definitions, unit-economics packages, protected operator metrics, board scorecards, and finance methodology gates are mapped.","proofRoutes":["/public-market-readiness","/api/public-market-readiness","/pilot-workspace/access"],"defendability":"Operating metrics connect product usage, workflow value, and governance proof for diligence.","retainedBoundary":"KPI readiness is not audited financial reporting, valuation assurance, or securities material."},{"name":"Interoperability-first synthetic validation","strength":"medium","evidence":"Standards registry, fixture validation, conformance evaluations, and synthetic workflow validation are visible before live integration.","proofRoutes":["/interoperability","/interoperability/evaluations","/integrations/fixture-validation"],"defendability":"Healthcare integration readiness is encoded as a repeatable evidence system.","retainedBoundary":"Synthetic validation does not approve live connectors or PHI ingestion."},{"name":"Commercial packaging and sales operations linkage","strength":"watch","evidence":"Pricing tiers, pilot programs, Deal Room, Sales Operations, attribution, and buyer workspaces are connected.","proofRoutes":["/pricing","/pilot-deal-room","/sales-operations","/attribution-analytics"],"defendability":"Revenue operations become inspectable and tied to proof instead of ad hoc founder selling.","retainedBoundary":"Sales packaging does not guarantee conversion, revenue, customer permission, or procurement approval."}],"investorReadinessMilestones":[{"name":"Category narrative packaged","status":"ready","investorQuestion":"What is SCRIMED building that is bigger than a feature?","evidence":"Healthcare Intelligence OS, public product console, and public-market thesis are live.","proofRoutes":["/healthcare-intelligence-os","/product","/public-market-readiness"],"fundingImpact":"Improves narrative clarity and makes the company easier to diligence.","retainedBoundary":"Narrative is operating posture, not an investment recommendation."},{"name":"Revenue streams mapped","status":"ready","investorQuestion":"How can SCRIMED make money before production clinical authority?","evidence":"Assessments, synthetic pilots, governance audits, blueprints, diligence rooms, and advisory work are packaged.","proofRoutes":["/capital-vitality","/pricing","/market-activation"],"fundingImpact":"Shows near-term non-PHI, synthetic, and review-only revenue paths.","retainedBoundary":"Revenue capability is not a sales forecast, audited result, or customer commitment."},{"name":"Proof stack deployed","status":"ready","investorQuestion":"Is the product real, inspectable, and deployed?","evidence":"Homepage, Hub, Product Console, Deal Room, APIs, briefs, smoke coverage, and production deployment exist.","proofRoutes":["/","/hub","/product","/pilot-deal-room"],"fundingImpact":"Reduces demo risk and gives reviewers direct inspection paths.","retainedBoundary":"Public proof stack does not prove protected customer production execution."},{"name":"Unit economics framework","status":"in-progress","investorQuestion":"Can SCRIMED measure cost, margin, and value by offer?","evidence":"Public Market Readiness defines cost-per-workflow, gross margin by offer, protected operator metrics, and finance methodology gates.","proofRoutes":["/public-market-readiness","/pilot-workspace/access"],"fundingImpact":"Creates the operating skeleton for future board and investor reporting.","retainedBoundary":"Framework is not audited financial reporting, accounting advice, tax advice, or valuation assurance."},{"name":"Claims and approvals controls","status":"ready","investorQuestion":"Can SCRIMED grow without overclaiming regulated authority?","evidence":"Approvals Readiness, Boundary Resolution, Clinical Authority Readiness, and Claim Guard are active.","proofRoutes":["/approvals-readiness","/boundary-resolution","/clinical-authority-readiness","/qa-claim-guard"],"fundingImpact":"Improves credibility with regulated buyers and risk-aware investors.","retainedBoundary":"Controls do not replace counsel, security assessors, regulators, or buyer approvers."},{"name":"Protected AAL2 proof retained","status":"operator-required","investorQuestion":"Can SCRIMED prove authenticated protected workflows without leaking secrets?","evidence":"Protected Manual QA Evidence and Buyer Proof Release exist, with browser AAL2 session requirements.","proofRoutes":["/qa-aal2-run-evidence","/qa-manual-execution-console","/pilot-workspace/access"],"fundingImpact":"Creates a path from public demo proof into protected diligence proof.","retainedBoundary":"Protected happy-path proof requires approved human AAL2 operation and no token retention."},{"name":"Funding data room sequence","status":"external-review-required","investorQuestion":"Which documents can be shared externally and under what authority?","evidence":"Buyer release-control chain can be repurposed as a funding-review release-control checklist.","proofRoutes":["/buyer-release-control-run","/pilot-workspace/access","/qa-buyer-proof-release"],"fundingImpact":"Clarifies how investor materials move through review without uncontrolled distribution.","retainedBoundary":"Funding materials require counsel and do not become securities offering material by default."},{"name":"Security and compliance evidence path","status":"external-review-required","investorQuestion":"What must happen before enterprise production trust claims?","evidence":"Provider security review readiness, procurement evidence routing, and Approvals Readiness tracks are mapped.","proofRoutes":["/approvals-readiness","/pilot-workspace/access","/trust-center"],"fundingImpact":"Shows a credible path toward enterprise-grade assurance without premature claims.","retainedBoundary":"Security posture is not SOC 2, HITRUST, HIPAA, pentest, or BAA execution."}],"fundingVitalityWorkstreams":[{"name":"Investor narrative brief","owner":"Founder + Product Console","status":"packaged","capability":"Use Capital Vitality brief as the top-level investor and board diligence summary.","proof":"/api/capital-vitality/brief","limitation":"Brief is not securities offering material or investment advice.","nextAction":"Review with counsel before using in fundraising or investor solicitation."},{"name":"Pilot conversion proof","owner":"Sales operations + Buyer Diligence","status":"active","capability":"Tie Deal Room, pricing, pilot intake, sales operations, and attribution analytics into one conversion path.","proof":"/pilot-deal-room, /pricing, /sales-operations, /attribution-analytics","limitation":"Conversion proof is operating evidence, not customer revenue guarantee.","nextAction":"Keep every opportunity source, buyer segment, offer, and next action tagged."},{"name":"Unit economics and board metrics","owner":"Finance + protected operator metrics owner","status":"operator-required","capability":"Collect no-PHI operator metrics, board scorecards, rollups, and methodology gates in protected workspaces.","proof":"/public-market-readiness and /pilot-workspace/access","limitation":"Protected metrics are not audited financial statements.","nextAction":"Use AAL2 protected capture for real operating metrics and preserve methodology notes."},{"name":"Security and compliance review packet","owner":"Security + legal + qualified external reviewers","status":"external-review-required","capability":"Package provider security reviews, procurement evidence routing, and approval tracks.","proof":"/approvals-readiness and /pilot-workspace/access","limitation":"Readiness packet is not security certification or legal approval.","nextAction":"Retain qualified reviewers before enterprise assurance language expands."},{"name":"Customer reference and public proof permission","owner":"Buyer Diligence + Release Steward + counsel","status":"external-review-required","capability":"Use release-control chain before any customer-specific evidence, logo, case study, or testimonial is shared.","proof":"/buyer-release-control-run","limitation":"No public customer proof is allowed without explicit approval and retained release evidence.","nextAction":"Keep distribution lockbox disabled until reviewer signoffs and recipient/access controls exist."},{"name":"Offer packaging and pricing discipline","owner":"Enterprise sales + product","status":"active","capability":"Keep assessments, pilots, governance audits, blueprints, protected pilots, and strategic partnerships packaged.","proof":"/pricing","limitation":"Pricing is non-binding and does not imply production authority or procurement acceptance.","nextAction":"Use fixed scopes and clear upgrade paths to protect margin and reduce buyer ambiguity."},{"name":"Competitive edge proof refresh","owner":"Founder + market activation + source intelligence","status":"active","capability":"Maintain moat signals as proof-backed operating claims rather than broad market assertions.","proof":"/competitive-edge, /source-intelligence, /market-activation","limitation":"Competitive positioning cannot imply third-party endorsement, partnership, certification, or guaranteed outcomes.","nextAction":"Refresh proof routes when product capabilities or external review posture changes."},{"name":"Legal and securities review","owner":"Founder + qualified counsel","status":"external-review-required","capability":"Separate operating readiness from fundraising solicitation, securities material, valuation, and investor advice.","proof":"/capital-vitality and /public-market-readiness","limitation":"SCRIMED cannot self-authorize investment materials or securities offering language.","nextAction":"Run any investor solicitation, SAFE/equity note, valuation, or offering deck through counsel."}],"proofRoutes":["/product","/pilot-deal-room","/pilots","/pricing","/pilot","/sales-operations","/approvals-readiness","/boundary-resolution","/clinical-authority-readiness","/trust-center","/agents","/workflows","/healthcare-intelligence-os","/interoperability","/pilot-workspace/access","/buyer-release-control-run","/trust-safety-operations","/qa-claim-guard","/claims","/deployment-profiles","/global-reach","/market-activation","/interoperability/evaluations","/integrations","/synthetic/validation","/atlas","/trust-os","/api/product/console","/trust","/source-intelligence","/workflows/results","/qa-buyer-proof-release","/service-reliability","/navigation","/release-continuity","/api/navigation-audit","/api/navigation-audit/brief","/public-market-readiness","/api/public-market-readiness","/integrations/fixture-validation","/attribution-analytics","/capital-vitality","/","/hub","/qa-aal2-run-evidence","/qa-manual-execution-console","/api/capital-vitality/brief","/public-market-readiness and /pilot-workspace/access","/approvals-readiness and /pilot-workspace/access","/competitive-edge","/capital-vitality and /public-market-readiness"],"nextCapitalMove":"Use Capital Vitality as the executive growth lane: sell packaged synthetic and governance offers now, keep protected buyer/funding proof gated through AAL2 and release controls, refresh moat evidence before claims expand, and route any fundraising, valuation, securities, legal, reimbursement, security, PHI, or live-care claim through qualified external review.","updated":"2026-06-24"},"marketActivationSummary":{"service":"scrimed-market-activation","status":"revenue-message-comms-foundation-ready","route":"/market-activation","apiRoute":"/api/market-activation","boundary":"SCRIMED market activation governs revenue, messaging, public relations, communications, advertising, and target-audience strategy for synthetic evaluations, readiness assessments, and protected pilots. It does not authorize medical claims, compliance certification claims, live clinical execution, payer submission, or patient outreach.","revenueStreamCount":5,"targetAudienceCount":8,"communicationsChannelCount":5,"advertisingCampaignCount":3,"faithCoreProgramCount":2,"revenueStreams":[{"name":"Workflow Intelligence Assessment","status":"ready-for-controlled-use","buyer":"Hospitals, clinics, payers, and healthcare transformation leaders with visible operational friction.","offer":"Fixed-fee workflow mapping, AI readiness, governance review, and executive decision packet.","priceSignal":"$50k floor; typical $75k-$150k.","conversionPath":"Official website -> Product Console -> Pilot Intake -> Sales Operations -> assessment invitation.","proofRoute":"/pricing","owner":"Enterprise sales","guardrails":["Do not request PHI.","Do not promise savings.","Frame findings as operational intelligence for human leaders."]},{"name":"Synthetic Pilot Evaluation","status":"ready-for-controlled-use","buyer":"Enterprise teams ready to test SCRIMED against synthetic workflows before integration.","offer":"45-90 day governed synthetic pilot with AgentOS, Atlas Trust Cards, proof packets, and observability.","priceSignal":"$150k floor; typical $200k-$500k.","conversionPath":"Demo Center -> Pilot Program -> no-PHI intake -> governance pack -> protected workspace planning.","proofRoute":"/pilots","owner":"Sales engineering and delivery","guardrails":["Synthetic data only.","No diagnosis, treatment, payer submission, or patient outreach.","Pilot metrics are directional business evidence."]},{"name":"Protected Enterprise Pilot","status":"approval-required","buyer":"Large health systems, payers, employers, and public-sector programs preparing controlled deployment.","offer":"Tenant-authenticated workspace, durable audit, activation governance, role-based review, and deployment profile planning.","priceSignal":"$750k floor; typical $1M-$2.5M.","conversionPath":"Synthetic pilot proof -> security/legal/privacy review -> protected workspace -> enterprise license proposal.","proofRoute":"/pilot-workspace","owner":"Enterprise sales, security, privacy, and implementation","guardrails":["Requires legal, privacy, security, and governance review.","Live PHI requires written approval and appropriate agreements.","Human review remains required."]},{"name":"Annual Healthcare Intelligence OS License","status":"approval-required","buyer":"Multi-site organizations expanding from one workflow to operating-layer adoption.","offer":"Annual platform access for AgentOS, Atlas, TrustOS, workflow modules, governance, observability, and support.","priceSignal":"$2.5M floor; enterprise range $3M-$12M+.","conversionPath":"Protected pilot -> value review -> deployment profile -> annual license -> expansion roadmap.","proofRoute":"/product","owner":"Executive enterprise sales","guardrails":["Separate platform license from implementation services.","Scope workflows, connectors, and support explicitly.","Do not imply unrestricted production permissions."]},{"name":"Strategic Platform Partnership","status":"external-review-required","buyer":"Governments, national programs, major payers, and strategic healthcare networks.","offer":"Multi-year healthcare intelligence infrastructure partnership with regional governance and deployment planning.","priceSignal":"$10M+ multi-year; national or ecosystem programs $25M+.","conversionPath":"Executive briefing -> sovereign/public-sector profile -> legal/procurement review -> strategic program.","proofRoute":"/deployment-profiles","owner":"Founder and strategic partnerships","guardrails":["No government approval claim.","Jurisdiction-specific legal and data-residency review required.","Public-sector claims must be reviewed before publication."]}],"targetAudiences":[{"segment":"Health system operations executives","priority":"primary","buyerTrigger":"Referral leakage, access delays, documentation burden, capacity strain, and fragmented work queues.","pain":"Operational teams lack decision-grade visibility across workflows before bottlenecks become expensive.","primaryOffer":"Workflow Intelligence Assessment","message":"SCRIMED transforms fragmented operational workflows into governed, human-reviewed intelligence that leaders can act on.","proofRoutes":["/product","/demos","/pilot-evidence"],"disqualifiers":["Buyer wants autonomous clinical decisions","Buyer requires live PHI in public intake"]},{"segment":"Payer and revenue cycle leaders","priority":"primary","buyerTrigger":"Denials, prior authorization friction, documentation gaps, and revenue leakage.","pain":"Administrative teams lose time and revenue when policy evidence and workflow risk are hard to see.","primaryOffer":"Synthetic Pilot Evaluation","message":"SCRIMED helps revenue and payer teams surface denial-risk, missing evidence, and policy friction through governed synthetic workflows.","proofRoutes":["/agents/revenue-cycle-agent","/workflows/results","/pricing"],"disqualifiers":["Buyer expects reimbursement guarantees","Buyer wants payer submission automation before approval"]},{"segment":"Security, privacy, legal, and governance buyers","priority":"primary","buyerTrigger":"AI adoption pressure, shadow AI risk, vendor diligence, BAA/DPA planning, and audit requirements.","pain":"Healthcare organizations need AI controls they can inspect before data exposure.","primaryOffer":"AI Readiness + Governance Audit","message":"SCRIMED gives healthcare AI buyers an inspectable trust layer with claims controls, audit trails, role boundaries, and activation governance.","proofRoutes":["/trust-center","/claims","/governance-packs"],"disqualifiers":["Buyer asks for compliance certification without audit","Buyer refuses human-review boundaries"]},{"segment":"Government and public-sector healthcare leaders","priority":"strategic","buyerTrigger":"National access, population health, sovereign data, workforce constraints, and digital transformation mandates.","pain":"Public systems need healthcare intelligence infrastructure that can be regionally governed and trusted.","primaryOffer":"Strategic Platform Partnership","message":"SCRIMED is building a healthcare intelligence infrastructure layer that can be evaluated with synthetic evidence before sovereign deployment decisions.","proofRoutes":["/deployment-profiles","/strategic-intelligence","/governance-packs"],"disqualifiers":["Buyer needs immediate public health reporting","Buyer requires jurisdictional approval before scoping"]},{"segment":"Life sciences and research operations leaders","priority":"strategic","buyerTrigger":"Trial matching delays, eligibility evidence gaps, oncology workflow friction, and research operations burden.","pain":"Research teams need explainable, reviewable operations intelligence without patient enrollment automation or treatment claims.","primaryOffer":"TrialCore Research Operations Synthetic Pilot","message":"SCRIMED can structure research operations evidence, eligibility gaps, and reviewer queues while keeping patient outreach, enrollment, and treatment recommendations gated.","proofRoutes":["/modules/trialcore","/demos/trialcore-research-operations","/global-reach"],"disqualifiers":["Buyer wants patient enrollment guarantees","Buyer bypasses research governance"]},{"segment":"Employers and benefits leaders","priority":"secondary","buyerTrigger":"Rising healthcare costs, access friction, care navigation gaps, and workforce health program complexity.","pain":"Employers need privacy-safe operational intelligence without becoming a medical decision-maker or exposing member data prematurely.","primaryOffer":"Workflow Intelligence Assessment","message":"SCRIMED helps employers evaluate access, navigation, and care-gap workflows through no-member-data assessment before any protected pilot.","proofRoutes":["/global-reach","/pilot-evidence","/trust-center"],"disqualifiers":["Buyer wants employee diagnosis","Buyer requires member data before agreements"]},{"segment":"Global channel partners and implementers","priority":"strategic","buyerTrigger":"Regional partners need differentiated healthcare AI infrastructure with trust, proof, and deployment readiness.","pain":"Partners need a credible operating layer and safe claims path before co-selling regulated healthcare AI.","primaryOffer":"Strategic Platform Partnership","message":"SCRIMED equips qualified partners with global buyer packs, deployment profiles, protected proof paths, and claims-safe regional positioning.","proofRoutes":["/global-reach","/deployment-profiles","/pilot-deal-room"],"disqualifiers":["Partner claims authorization without agreement","Partner lacks healthcare-grade security posture"]},{"segment":"Faith-aligned care, community, and patient-experience leaders","priority":"secondary","buyerTrigger":"Desire for dignity, trust, encouragement, spiritual support, and culturally sensitive patient experience.","pain":"Faith-aligned support is often disconnected from clinical safety, consent, and professional boundaries.","primaryOffer":"FaithCore Trust And Encouragement Layer","message":"FaithCore provides opt-in spiritual encouragement and dignity-centered trust support while keeping clinical judgment and emergency care with qualified professionals.","proofRoutes":["/faithcore","/operating-context","/trust-center"],"disqualifiers":["Buyer wants spiritual guidance to replace clinical care","Buyer does not accept opt-in consent boundaries"]}],"messageHouse":{"coreMessage":"SCRIMED is the governed healthcare intelligence operating layer that turns fragmented workflows into evidence-backed, human-reviewed operational intelligence.","positioning":"Not a chatbot, not an ambient scribe alone, and not a consulting wrapper. SCRIMED is an AI-native healthcare infrastructure platform for workflows, agents, interoperability, trust, and proof.","approvedProofPoints":["Governed synthetic pilots and enterprise evaluations are available now.","AgentOS, Atlas, TrustOS, protected workspaces, proof packets, and governance packs are inspectable in the product.","SCRIMED maintains clear boundaries: synthetic-only public flows, human review, no autonomous diagnosis, no payer submission, and no live clinical execution without approvals.","Global Reach maps regions, buyer packs, partner paths, procurement questions, and retained gates before international expansion claims scale.","Revenue value is measured through time saved, workflow friction reduced, documentation quality, denial-risk signals, access bottlenecks, and trust completeness."],"toneRules":["Use confident enterprise language without hype.","Lead with trust, outcomes, interoperability, and operational intelligence.","Use FaithCore only as opt-in dignity, encouragement, and trust support.","Separate vision from current capability."],"prohibitedClaims":["HIPAA certified","SOC 2 certified","FDA cleared","guaranteed revenue","guaranteed reimbursement","autonomous diagnosis","treats patients","government approved"]},"communicationsPlaybook":[{"channel":"Official website","status":"ready-for-controlled-use","audience":"Executives, buyers, advisors, investors, and partners.","message":"SCRIMED is the governed healthcare intelligence operating layer that turns fragmented workflows into evidence-backed, human-reviewed operational intelligence.","proofAsset":"/product","approvalGate":"Claims must match the public claims register before publishing."},{"channel":"Founder and investor narrative","status":"ready-for-controlled-use","audience":"Investors, advisors, strategic partners, and enterprise champions.","message":"SCRIMED is building the trusted healthcare intelligence infrastructure layer for global healthcare workflows.","proofAsset":"/strategic-intelligence","approvalGate":"Vision statements must remain separate from current sellable pilot capability."},{"channel":"Public relations","status":"approval-required","audience":"Healthcare business media, innovation leaders, community stakeholders, and ecosystem partners.","message":"SCRIMED is advancing governed AI for healthcare operations through synthetic pilots, trust controls, and interoperability-first product design.","proofAsset":"/trust-center","approvalGate":"Legal, privacy, brand, and claims-control review before distribution."},{"channel":"Enterprise sales outreach","status":"ready-for-controlled-use","audience":"Named healthcare executives and workflow owners.","message":"SCRIMED can run a governed synthetic evaluation of high-friction workflows before live data, production connectors, or clinical execution are considered.","proofAsset":"/pilot","approvalGate":"No PHI requests, no guarantees, and no compliance certification claims."},{"channel":"Incident, trust, and public response","status":"approval-required","audience":"Customers, public stakeholders, regulators, and partners where applicable.","message":"SCRIMED communicates boundaries, evidence, impact, and corrective actions through a documented trust and governance process.","proofAsset":"/claims","approvalGate":"Security, privacy, legal, and communications approval required."}],"advertisingCampaigns":[{"channel":"LinkedIn executive demand generation","status":"approval-required","targetAudience":"Health system operations, payer operations, revenue cycle, AI governance, and healthcare transformation executives.","objective":"Drive qualified enterprise pilot intake and assessment calls.","landingRoute":"/pilot","budgetPosture":"Start with controlled small-budget tests after abuse monitoring and claim review.","conversionEvent":"No-PHI pilot intake with boundary acknowledgement.","claimControl":"Use approved pilot, workflow, trust, and interoperability claims only.","blockedClaims":["clinical outcome guarantees","HIPAA certified","reimbursement guaranteed"]},{"channel":"Search advertising","status":"approval-required","targetAudience":"Buyers searching for healthcare AI governance, workflow automation, prior authorization AI, RCM AI, and interoperability readiness.","objective":"Capture high-intent buyer research and route to Product Console or Pilot Intake.","landingRoute":"/product","budgetPosture":"Delay scale until intake abuse controls, CRM routing, and campaign review are active.","conversionEvent":"Product console engagement or pilot intake.","claimControl":"Avoid disease, treatment, diagnosis, and guaranteed savings language.","blockedClaims":["diagnosis automation","patient treatment","guaranteed ROI"]},{"channel":"FaithCore community awareness","status":"approval-required","targetAudience":"Faith-aligned health leaders, patient-experience teams, community health organizations, and chaplaincy-adjacent stakeholders.","objective":"Position FaithCore as opt-in dignity and encouragement support with clear clinical boundaries.","landingRoute":"/faithcore","budgetPosture":"Use careful organic and partner-led education before paid campaigns.","conversionEvent":"FaithCore discovery call or enterprise trust assessment.","claimControl":"Spiritual encouragement only; no medical, mental health, emergency, or pastoral authority claims.","blockedClaims":["replaces clinician","replaces chaplain","heals","emergency support"]}],"faithCoreMarketPrograms":[{"name":"FaithCore Trust And Encouragement Layer","status":"ready-for-controlled-use","audience":"Opt-in patients, communities, and care teams that value spiritually aligned support.","message":"FaithCore supports dignity, hope, and trust while keeping clinical care, consent, and emergency decisions with qualified professionals.","useCase":"Patient-experience, community trust, culturally sensitive support, and whole-person encouragement.","revenueUse":"Add-on to patient-experience, community health, and faith-aligned enterprise pilots after governance review.","route":"/faithcore","boundaries":["Opt-in only","No diagnosis or treatment","No emergency guidance","No replacement for clinicians, chaplains, counselors, or professional care","Culturally sensitive and faith-aware, not coercive"]},{"name":"FaithCore Staff Resilience And Mission Alignment","status":"approval-required","audience":"Care teams and organizations seeking values-aligned reflection and encouragement.","message":"FaithCore can support values-based reflection and staff encouragement without becoming HR, clinical, or pastoral authority.","useCase":"Staff resilience pilots, mission-centered reflection, and ethical culture support.","revenueUse":"Enterprise add-on for organizations that explicitly opt into FaithCore programming.","route":"/faithcore","boundaries":["No employment advice","No mental health treatment","No coercive faith participation","Human leadership and professional support remain accountable"]}],"nextBuildStep":"Use Attribution Analytics to review source-to-pilot cohorts before scaling campaigns, then add tenant-admin export packets for board, investor, and enterprise pipeline reviews.","updated":"2026-06-15"},"commercialStrategySummary":{"service":"scrimed-commercial-strategy","route":"/pricing","apiRoute":"/api/commercial/pricing","status":"pricing-and-sales-motion-ready","recommendedModel":"Hybrid enterprise model: free public preview, paid assessment, paid synthetic pilot, protected enterprise pilot, annual platform license, and custom strategic partnerships.","recommendedAppDomain":"app.scrimedsolutions.com","boundary":"SCRIMED pricing and sales motions currently sell governed synthetic evaluations, readiness assessments, and protected enterprise pilots. Pricing does not imply live clinical execution, autonomous diagnosis, payer submission, reimbursement guarantees, or production medical-record processing.","productAccessRoutes":[{"surface":"Official Wix website","route":"https://www.scrimedsolutions.com","buyerIntent":"Brand discovery, credibility, founder story, high-level product education, and public contact capture.","owner":"SCRIMED marketing site"},{"surface":"Vercel app subdomain","route":"https://app.scrimedsolutions.com","buyerIntent":"Product console, AgentOS evaluation, pilot intake, pricing, trust, workflows, and enterprise proof stack.","owner":"SCRIMED product platform"},{"surface":"Product Console","route":"/product","buyerIntent":"Inspect sellable offers, workflow examples, proof stack, governance controls, and readiness brief.","owner":"Product and sales"},{"surface":"Demo Center","route":"/demos","buyerIntent":"Inspect executable product demos, proof routes, outcome signals, governance boundaries, and production exclusions.","owner":"Sales engineering and product"},{"surface":"Pilot Programs","route":"/pilots","buyerIntent":"Compare structured enterprise programs by duration, deliverables, inputs, metrics, gates, and engagement model.","owner":"Enterprise sales and delivery"},{"surface":"Pilot Deal Room","route":"/pilot-deal-room","buyerIntent":"Understand how SCRIMED moves from public product proof to sales opportunity, Buyer Pilot Room, audited packet, and paid pilot.","owner":"Enterprise sales and product"},{"surface":"AgentOS Evaluation Workspace","route":"/evaluation","buyerIntent":"Run a synthetic workflow packet through AgentOS and Atlas Trust Cards before a sales call.","owner":"Sales engineering"},{"surface":"Pilot Intake","route":"/pilot","buyerIntent":"Request an assessment, synthetic pilot, governance audit, or automation blueprint.","owner":"Enterprise sales"}],"pricingTiers":[{"name":"Public Product Preview","status":"public-preview","recommendedDisplayPrice":"Free public access","buyer":"Website visitors, investors, advisors, and early enterprise evaluators","entryCriteria":["No account required","No PHI or live data submitted","Buyer is learning SCRIMED's product category and trust posture"],"includes":["Product Console","AgentOS Evaluation Workspace using synthetic examples","Trust, workflow, pricing, and readiness surfaces","Downloadable readiness brief"],"successMetric":"Qualified buyer moves from education to pilot intake.","expansionPath":"Synthetic Pilot Evaluation","boundary":"Public preview is a product education surface, not a live clinical system.","primaryAction":{"label":"Open Product Console","href":"/product"}},{"name":"Workflow Intelligence Assessment","status":"sellable-now","recommendedDisplayPrice":"Standard $25k-$75k; mission-clinic access path $12.5k-$25k for one no-PHI workflow; enterprise assessment $75k-$150k","buyer":"Hospitals, clinics, payers, and transformation teams validating workflow opportunity before a pilot","entryCriteria":["Executive or operational sponsor identified","One to three workflows selected","Buyer can describe current process, constraints, and governance needs"],"includes":["Workflow friction map","AI readiness and governance review","Interoperability target map","AgentOS evaluation packet","Executive findings call"],"successMetric":"Buyer approves pilot scope, value hypothesis, and governance gates.","expansionPath":"Synthetic Pilot Evaluation or AI Readiness + Governance Audit","boundary":"Assessment produces operational intelligence for human leaders; it is not clinical advice.","primaryAction":{"label":"Book Assessment","href":"/pilot?offer=workflow-intelligence-assessment"}},{"name":"Synthetic Pilot Evaluation","status":"sellable-now","recommendedDisplayPrice":"Standard $125k-$350k for 45-90 days; $350k-$500k when multiple workflows, diligence, or executive proof packets expand scope","buyer":"Enterprise buyers who want to evaluate SCRIMED against synthetic workflows before live integration","entryCriteria":["Named sponsor and review team","Synthetic workflow packet approved","Pilot outcome metrics selected","No live PHI or production connector required"],"includes":["AgentOS orchestration for selected workflows","Atlas Trust Cards and evidence source mapping","Synthetic workflow result packets","Audit and observability report","Production-readiness decision register"],"successMetric":"Buyer validates workflow value, trust posture, and protected-pilot business case.","expansionPath":"Protected Enterprise Pilot","boundary":"Synthetic data only; no diagnosis, treatment, payer submission, or patient outreach.","primaryAction":{"label":"Request Pilot","href":"/pilot?offer=synthetic-pilot-evaluation"}},{"name":"Protected Enterprise Pilot","status":"protected-pilot","recommendedDisplayPrice":"Standard $400k-$1.25M for 90-180 days; $1.25M-$2M+ for multi-site, protected diligence, sandbox planning, or expanded scope","buyer":"Health systems, payers, public-sector programs, and enterprise operators preparing controlled deployment","entryCriteria":["Security, privacy, compliance, and legal review underway","BAA and data-boundary decisions defined","Tenant identity and reviewer roles approved","Workflow owner and success baseline confirmed"],"includes":["Tenant-scoped pilot environment","Role-based review workflows","Connector implementation plan","Durable audit design","Operational outcomes report","Enterprise license proposal"],"successMetric":"Buyer approves annual operating license, connector scope, and governed production plan.","expansionPath":"Enterprise Operating License","boundary":"Protected pilot still requires human review and approved controls before any live clinical workflow use.","primaryAction":{"label":"Start Protected Pilot","href":"/pilot?offer=clinical-operations-automation-blueprint"}},{"name":"Enterprise Operating License","status":"enterprise-license","recommendedDisplayPrice":"Initial annual operating layer $1.5M-$6M; multi-department or multi-region expansion $6M-$12M+","buyer":"Large hospitals, payers, government health agencies, and multi-site healthcare organizations","entryCriteria":["Protected pilot validated","Approved identity, audit, security, connector, and governance controls","Annual budget owner identified","Expansion workflows prioritized"],"includes":["SCRIMED AgentOS and Atlas operating layer","Workflow, agent, and connector packages","TrustQA, audit, observability, and governance stack","Enterprise support and implementation cadence","Quarterly value and safety reviews"],"successMetric":"Multi-workflow expansion with measurable operational value and governed trust posture.","expansionPath":"Strategic Platform Partnership","boundary":"Production use requires signed controls, approved workflows, and human-review operating procedures.","primaryAction":{"label":"Contact Enterprise Sales","href":"/pilot?offer=ai-readiness-governance-audit"}},{"name":"Strategic Platform Partnership","status":"strategic","recommendedDisplayPrice":"Multi-year partnerships $8M-$25M+, sales-led, region-aware, and external-review-gated","buyer":"Governments, national health systems, major payers, strategic hospital networks, and global partners","entryCriteria":["Multi-organization mandate","Long-term interoperability, governance, or transformation program","Executive steering committee","Regional compliance and deployment model defined"],"includes":["Dedicated roadmap alignment","Regional compliance and sovereignty planning","Custom agent and connector strategy","Executive governance reporting","Strategic implementation support"],"successMetric":"SCRIMED becomes a governed healthcare intelligence infrastructure partner.","expansionPath":"Regional or ecosystem-level deployment","boundary":"Strategic work remains governed, auditable, human-reviewed, and regionally compliant.","primaryAction":{"label":"Request Strategic Review","href":"/pilot?offer=ai-readiness-governance-audit"}}],"premiumPricingPrinciples":[{"principle":"Protect enterprise price integrity","policy":"Use starts-at floors and scoped enterprise ranges; do not publish low monthly plans for the operating layer.","rationale":"SCRIMED sells governed healthcare intelligence infrastructure, workflow transformation, trust controls, and enterprise proof, not a commodity chatbot seat.","guardrail":"Discount only by reducing scope, duration, services, integrations, or support commitments."},{"principle":"Price against workflow value and governance scope","policy":"Anchor fees to workflows under governance, departments served, integrations, support level, security review, and proof-stack depth.","rationale":"Healthcare buyers pay for measurable operational intelligence, trusted controls, and deployment readiness across high-friction workflows.","guardrail":"Measured pilot outcomes are directional business evidence, not guaranteed clinical, payer, or reimbursement outcomes."},{"principle":"Separate platform license from implementation services","policy":"Keep annual platform licensing distinct from assessment, pilot, connector, migration, security, training, and advisory work.","rationale":"This preserves SCRIMED's long-term platform margin while making complex enterprise delivery transparent to buyers.","guardrail":"Live connector, PHI, clinical, payer, or sovereign deployment work requires approved written scope and controls."},{"principle":"Move qualified buyers toward multi-year commitments","policy":"Use paid assessments and synthetic pilots to validate scope, then convert protected pilots into annual or multi-year platform agreements.","rationale":"Enterprise healthcare transformation compounds through trust, workflow ownership, integrations, and institutional memory.","guardrail":"No customer should enter production use without legal, privacy, security, governance, and human-review approvals."}],"salesMotion":[{"phase":"discover","name":"Website to Product","route":"https://www.scrimedsolutions.com -> https://app.scrimedsolutions.com/product","buyerAction":"Buyer learns the brand on Wix and clicks into the SCRIMED product app.","scrimedAction":"Route buyer to Product Console, Pricing, Evaluation, or Pilot Intake.","qualificationGate":"Buyer has healthcare workflow, governance, interoperability, or AI readiness need.","nextCommitment":"Run evaluation or submit pilot intake."},{"phase":"evaluate","name":"Self-Guided Product Evaluation","route":"/evaluation","buyerAction":"Buyer inspects synthetic AgentOS/Atlas outputs without needing Vercel or an account.","scrimedAction":"Package product proof around task plans, Trust Cards, audit preview, and observability.","qualificationGate":"Buyer confirms one or more high-value workflows and a sponsor.","nextCommitment":"Paid assessment or synthetic pilot."},{"phase":"pilot","name":"Paid Evaluation or Synthetic Pilot","route":"/pilot-deal-room","buyerAction":"Buyer reviews the Pilot Deal Room, requests scoped assessment or pilot, and acknowledges no-PHI boundary.","scrimedAction":"Qualify buyer, define scope, metrics, governance gates, decision criteria, and deal-room packet.","qualificationGate":"Sponsor, budget range, workflow owner, review team, and pilot success metrics exist.","nextCommitment":"Protected pilot or annual license proposal."},{"phase":"license","name":"Protected Pilot to Enterprise License","route":"/pricing","buyerAction":"Buyer reviews implementation, security, compliance, and annual operating model.","scrimedAction":"Propose base platform license plus workflow, connector, agent, support, and usage scope.","qualificationGate":"BAA, identity, audit, connector, security, and human-review controls approved.","nextCommitment":"Annual enterprise agreement."},{"phase":"expand","name":"Enterprise Expansion","route":"/observability","buyerAction":"Buyer expands from one workflow to multiple departments, regions, or organizations.","scrimedAction":"Use observability, trust metrics, and governance reporting to support expansion.","qualificationGate":"Measured value and safety posture remain strong under review.","nextCommitment":"Multi-year strategic partnership."}],"valueMetrics":[{"metric":"Workflows under governance","whyItMatters":"Healthcare buyers buy workflow transformation, not generic AI usage.","pricingUse":"Primary enterprise package metric for pilots and annual licenses.","guardrail":"Workflow expansion requires approved human-review and audit controls."},{"metric":"Agent and service modules enabled","whyItMatters":"Sanar AI, DocuTwin, CareExplain, Ambient Scribe, TrialCore, PayerIQ, and future services carry different value and risk.","pricingUse":"Module add-ons and tier expansion.","guardrail":"No module implies autonomous diagnosis, treatment, payer submission, or patient outreach."},{"metric":"Connector and integration scope","whyItMatters":"EHR, payer, CRM, knowledge, and analytics connectors drive implementation cost and enterprise value.","pricingUse":"Implementation and annual support scope.","guardrail":"Live connectors require BAA, tenant identity, audit, security, and approval controls."},{"metric":"Evaluation and task volume","whyItMatters":"AI-heavy usage should scale with actual activity without surprising buyers.","pricingUse":"Usage band or credit pool after pilot validation.","guardrail":"Usage pricing should be capped or contracted to preserve buyer trust."},{"metric":"Organizations, regions, and departments","whyItMatters":"SCRIMED can expand from department workflow to enterprise operating layer.","pricingUse":"Enterprise and strategic partnership expansion.","guardrail":"Regional compliance, data residency, language, and governance needs must be explicit."}],"commercialGuardrails":[{"guardrail":"Do not publish low consumer-style pricing","detail":"SCRIMED is an enterprise healthcare operating layer. Public pricing should show package ranges or 'starts at' for evaluations, with enterprise pilots handled by sales."},{"guardrail":"Sell outcomes as measured pilot signals","detail":"Use time saved, workflow friction, denial risk, access bottlenecks, documentation quality, and trust completeness as pilot metrics, not unsupported clinical claims."},{"guardrail":"Separate public preview from paid pilots","detail":"Website visitors can inspect the product, but paid assessments and pilots require sponsor, workflow scope, governance needs, and no-PHI acknowledgement."},{"guardrail":"Keep medical-device and clinical claims out of sales copy","detail":"SCRIMED should present as governed operational intelligence until clinical, regulatory, and production execution controls are explicitly approved."},{"guardrail":"Use enterprise sales with sales engineering","detail":"Healthcare buyers need security, compliance, workflow, interoperability, ROI, and trust review before annual license commitment."}],"marketPricingBenchmarks":[{"segment":"Individual AI scribe subscriptions","publicSignal":"Freed, Tali, and Heidi show free or low monthly clinician entry points for narrow documentation workflows.","source":"Public competitor pricing pages and plan pages","scrimedImplication":"SCRIMED should not compete as a low-cost per-seat scribe; free demos are the entry point, while paid work is enterprise workflow, governance, interoperability, and proof packaging."},{"segment":"Enterprise clinical AI assistants","publicSignal":"Suki, Ambience, Abridge, and similar vendors lead with workflow breadth, EHR adjacency, specialty support, and sales-led enterprise pricing.","source":"Public enterprise product pages and case-study positioning","scrimedImplication":"SCRIMED pilot pricing should scale by workflow family, departments, governance burden, proof depth, implementation complexity, and protected controls."},{"segment":"Healthcare integration infrastructure","publicSignal":"Redox-style integration platforms use custom pricing because EHR connectivity, uptime, security, data exchange, and trading-partner requirements drive cost.","source":"Public healthcare integration product and pricing-positioning pages","scrimedImplication":"Connector and production data-exchange work must remain outside standard demo and synthetic-pilot prices until separately reviewed and priced."},{"segment":"Health-system-owned AI infrastructure","publicSignal":"The 2026 Berta open-source scribe paper reports commercial AI scribes at $99-$600 per physician per month and internal operating costs below $30 per physician per month.","source":"Berta arXiv paper","scrimedImplication":"SCRIMED must defend enterprise price through proof, governance, safety, workflow redesign, interoperability readiness, and margin-transparent implementation."}],"pricingAlignmentDecisions":[{"lane":"Public demos","decision":"Keep free, no-PHI, no-account public demos and qualified standard guided demos.","rationale":"Market leaders reduce friction with trials or low-cost entry before enterprise review.","marginProtection":"Custom prep, questionnaires, buyer-specific proof packets, and diligence release work move into paid scope."},{"lane":"Assessments","decision":"Use $25k-$75k as the standard assessment band, with a $12.5k-$25k mission-clinic access path and $75k-$150k enterprise assessment band.","rationale":"This stays approachable for early buyers without pricing SCRIMED like a commodity seat subscription.","marginProtection":"Cap workflow count, meetings, artifacts, and review cycles; discount only by reducing scope."},{"lane":"Synthetic pilots","decision":"Use $125k-$350k as the standard 45-90 day synthetic pilot band and $350k-$500k for expanded proof scope.","rationale":"Enterprise pilots should be materially above individual scribe subscriptions while staying below production integration commitments.","marginProtection":"Separate custom packets, protected workspaces, integration planning, legal/security diligence, and implementation labor."},{"lane":"Protected enterprise pilots","decision":"Use $400k-$1.25M as the standard 90-180 day protected pilot band and $1.25M-$2M+ for multi-site or heavy diligence scope.","rationale":"Protected pilots carry security, privacy, tenant, evidence-room, support, and connector-readiness costs.","marginProtection":"Separate annual license, services, support, model usage, evidence-room release, connector work, and change orders."},{"lane":"Enterprise operating license","decision":"Use $1.5M-$6M annual for initial enterprise layer and $6M-$12M+ for multi-department or multi-region expansion.","rationale":"This aligns with infrastructure-level value while giving buyers a believable expansion ladder after pilots prove value.","marginProtection":"Keep implementation, support, connector, usage, and continuous review retainers out of the base license unless explicitly priced."}],"updated":"2026-06-26"},"publicMarketReadinessSummary":{"service":"scrimed-public-market-readiness","route":"/public-market-readiness","apiRoute":"/api/public-market-readiness","briefRoute":"/api/public-market-readiness/brief","protectedOperatorMetricRoute":"/pilot-workspace/access","protectedOperatorMetricApiRoute":"/api/pilot-workspaces/{workspaceSlug}/operator-metrics","protectedMetricRollupRoute":"/pilot-workspace/access","protectedMetricRollupApiRoute":"/api/pilot-workspaces/{workspaceSlug}/metric-rollups","protectedMetricRollupPacketApiRoute":"/api/pilot-workspaces/{workspaceSlug}/metric-rollups/{snapshotId}/packet","protectedMetricTrendRoute":"/pilot-workspace/access","protectedMetricTrendApiRoute":"/api/pilot-workspaces/{workspaceSlug}/metric-trends","protectedMetricTrendPacketApiRoute":"/api/pilot-workspaces/{workspaceSlug}/metric-trends/{reviewId}/packet","protectedBoardScorecardRoute":"/pilot-workspace/access","protectedBoardScorecardApiRoute":"/api/pilot-workspaces/{workspaceSlug}/board-scorecards","protectedBoardScorecardPacketApiRoute":"/api/pilot-workspaces/{workspaceSlug}/board-scorecards/{scorecardId}/packet","protectedFinanceMethodologyRoute":"/pilot-workspace/access","protectedFinanceMethodologyApiRoute":"/api/pilot-workspaces/{workspaceSlug}/finance-methodology","protectedFinanceMethodologyPacketApiRoute":"/api/pilot-workspaces/{workspaceSlug}/finance-methodology/packet","protectedExternalApprovalEvidenceRoute":"/pilot-workspace/access","protectedExternalApprovalEvidenceApiRoute":"/api/pilot-workspaces/{workspaceSlug}/external-approval-evidence","protectedExternalApprovalEvidencePacketApiRoute":"/api/pilot-workspaces/{workspaceSlug}/external-approval-evidence/packet","protectedReleaseDecisionRoute":"/pilot-workspace/access","protectedReleaseDecisionApiRoute":"/api/pilot-workspaces/{workspaceSlug}/release-decisions","protectedReleaseDecisionPacketApiRoute":"/api/pilot-workspaces/{workspaceSlug}/release-decisions/packet","protectedNamedReviewerSignoffRoute":"/pilot-workspace/access","protectedNamedReviewerSignoffApiRoute":"/api/pilot-workspaces/{workspaceSlug}/reviewer-signoffs","protectedNamedReviewerSignoffPacketApiRoute":"/api/pilot-workspaces/{workspaceSlug}/reviewer-signoffs/packet","protectedDistributionLockboxRoute":"/pilot-workspace/access","protectedDistributionLockboxApiRoute":"/api/pilot-workspaces/{workspaceSlug}/distribution-lockbox","protectedDistributionLockboxPacketApiRoute":"/api/pilot-workspaces/{workspaceSlug}/distribution-lockbox/packet","protectedReleaseAuthorityAttestationRoute":"/pilot-workspace/access","protectedReleaseAuthorityAttestationApiRoute":"/api/pilot-workspaces/{workspaceSlug}/release-authority-attestations","protectedReleaseAuthorityAttestationPacketApiRoute":"/api/pilot-workspaces/{workspaceSlug}/release-authority-attestations/packet","protectedEvidenceRoomRecipientAttestationRoute":"/pilot-workspace/access","protectedEvidenceRoomRecipientAttestationApiRoute":"/api/pilot-workspaces/{workspaceSlug}/evidence-room-recipient-attestations","protectedEvidenceRoomRecipientAttestationPacketApiRoute":"/api/pilot-workspaces/{workspaceSlug}/evidence-room-recipient-attestations/packet","protectedEvidenceRoomAccessLogReconciliationRoute":"/pilot-workspace/access","protectedEvidenceRoomAccessLogReconciliationApiRoute":"/api/pilot-workspaces/{workspaceSlug}/evidence-room-access-log-reconciliation","protectedEvidenceRoomAccessLogReconciliationPacketApiRoute":"/api/pilot-workspaces/{workspaceSlug}/evidence-room-access-log-reconciliation/packet","protectedEvidenceRoomProviderAdapterRoute":"/pilot-workspace/access","protectedEvidenceRoomProviderAdapterApiRoute":"/api/pilot-workspaces/{workspaceSlug}/evidence-room-provider-adapters","protectedEvidenceRoomProviderAdapterPacketApiRoute":"/api/pilot-workspaces/{workspaceSlug}/evidence-room-provider-adapters/packet","protectedProviderSecurityReviewRoute":"/pilot-workspace/access","protectedProviderSecurityReviewApiRoute":"/api/pilot-workspaces/{workspaceSlug}/provider-security-reviews","protectedProviderSecurityReviewPacketApiRoute":"/api/pilot-workspaces/{workspaceSlug}/provider-security-reviews/packet","protectedProcurementEvidenceRegistryRoute":"/pilot-workspace/access","protectedProcurementEvidenceRegistryApiRoute":"/api/pilot-workspaces/{workspaceSlug}/procurement-evidence","protectedProcurementEvidenceRegistryPacketApiRoute":"/api/pilot-workspaces/{workspaceSlug}/procurement-evidence/packet","status":"capital-efficiency-kpi-stack-ready","proofStackStatus":"public-market-readiness-capital-efficiency-kpi-stack","briefProofStackStatus":"public-market-readiness-board-brief-no-financial-advice","protectedOperatorMetricStatus":"aal2-protected-operator-metric-capture-no-phi","protectedMetricRollupStatus":"aal2-finance-reviewed-metric-rollups-no-phi","protectedMetricRollupPacketStatus":"aal2-audited-board-metric-packets-no-phi","protectedMetricTrendStatus":"aal2-board-trend-review-no-phi","protectedMetricTrendPacketStatus":"aal2-audited-board-trend-packets-no-phi","protectedBoardScorecardStatus":"aal2-rolling-quarter-board-scorecards-no-phi","protectedBoardScorecardPacketStatus":"aal2-audited-board-scorecard-packets-no-phi","protectedFinanceMethodologyStatus":"aal2-finance-methodology-gates-no-phi","protectedFinanceMethodologyPacketStatus":"aal2-audited-finance-methodology-gate-packets-no-phi","protectedExternalApprovalEvidenceStatus":"aal2-qualified-external-approval-evidence-links-no-phi","protectedExternalApprovalEvidencePacketStatus":"aal2-audited-external-approval-evidence-link-packets-no-phi","protectedReleaseDecisionStatus":"aal2-qualified-release-decision-workflow-no-phi","protectedReleaseDecisionPacketStatus":"aal2-audited-release-decision-claim-registry-packets-no-phi","protectedNamedReviewerSignoffStatus":"aal2-named-reviewer-signoff-metadata-no-phi","protectedNamedReviewerSignoffPacketStatus":"aal2-audited-named-reviewer-signoff-packets-no-phi","protectedDistributionLockboxStatus":"aal2-external-distribution-lockbox-disabled-no-phi","protectedDistributionLockboxPacketStatus":"aal2-audited-distribution-lockbox-packets-no-phi","protectedReleaseAuthorityAttestationStatus":"aal2-external-release-authority-attestations-disabled-no-phi","protectedReleaseAuthorityAttestationPacketStatus":"aal2-audited-release-authority-attestation-packets-no-phi","protectedEvidenceRoomRecipientAttestationStatus":"aal2-evidence-room-recipient-attestations-disabled-no-phi","protectedEvidenceRoomRecipientAttestationPacketStatus":"aal2-audited-evidence-room-recipient-attestation-packets-no-phi","protectedEvidenceRoomAccessLogReconciliationStatus":"aal2-evidence-room-access-log-reconciliation-disabled-no-phi","protectedEvidenceRoomAccessLogReconciliationPacketStatus":"aal2-audited-evidence-room-access-log-reconciliation-packets-no-phi","protectedEvidenceRoomProviderAdapterStatus":"aal2-evidence-room-provider-adapter-contracts-disabled-no-phi","protectedEvidenceRoomProviderAdapterPacketStatus":"aal2-audited-evidence-room-provider-adapter-packets-no-phi","protectedProviderSecurityReviewStatus":"aal2-provider-security-review-workbench-no-phi","protectedProviderSecurityReviewPacketStatus":"aal2-audited-provider-security-review-packets-no-phi","protectedProcurementEvidenceRegistryStatus":"aal2-procurement-evidence-registry-no-sensitive-artifacts","protectedProcurementEvidenceRegistryPacketStatus":"aal2-audited-procurement-evidence-registry-packets-no-sensitive-artifacts","thesis":"SCRIMED is healthcare intelligence infrastructure, not another AI model company.","investorNarrative":"While frontier labs burn billions to build general intelligence, SCRIMED captures healthcare-specific value by owning the workflow, trust layer, data loops, governance evidence, interoperability path, and measurable outcomes around healthcare operations.","efficientHealthcareIntelligence":"SCRIMED should own healthcare workflows, trust evidence, and outcomes while using model routing, task-specific agents, open/closed model optionality, and token-cost controls to avoid frontier-model dependency.","boundary":"SCRIMED Public Market Readiness organizes KPI definitions, unit-economics discipline, compliance logs, customer proof, governance documentation, model-efficiency controls, and investor narrative for enterprise operating maturity. It is not audited financial reporting, securities offering material, investment advice, accounting advice, tax advice, a valuation guarantee, clinical validation, reimbursement assurance, compliance certification, or live clinical execution authorization.","metricCount":10,"unitEconomicsPackageCount":4,"modelEfficiencyControlCount":4,"complianceLogCount":6,"customerProofStageCount":5,"boardCadenceCount":4,"limitationCount":5,"operatorMetricCatalogCount":5,"operatingMetrics":[{"id":"cost-per-workflow","name":"Cost per governed workflow","category":"unit-economics","unit":"USD per completed workflow packet","formula":"(model cost + infrastructure cost + review labor + support allocation) / completed governed workflow packets","targetDirection":"lower-is-better","currentMaturity":"synthetic-measurement-ready","auditSource":"AgentOS task trace, QA evidence ledger, proof-packet release audit, and workflow result validation.","proofRoute":"/workflows/results","boundary":"Synthetic and protected-pilot workflows only until buyer-approved production baselines exist."},{"id":"cost-per-patient-interaction","name":"Cost per patient interaction equivalent","category":"unit-economics","unit":"USD per synthetic or approved pilot interaction","formula":"(agent execution cost + routing cost + human-review cost) / synthetic or approved pilot interaction count","targetDirection":"lower-is-better","currentMaturity":"protected-pilot-measurement-required","auditSource":"Protected pilot sessions, buyer demo sessions, and approved customer baselines.","proofRoute":"/pilot-workspace/access","boundary":"No live patient interaction is authorized. Current use is a pilot-equivalent metric definition."},{"id":"cost-per-chart","name":"Cost per chart review","category":"unit-economics","unit":"USD per synthetic or approved chart-review work order","formula":"(document intelligence cost + model extraction cost + TrustQA review cost + reviewer time) / chart-review work orders","targetDirection":"lower-is-better","currentMaturity":"synthetic-measurement-ready","auditSource":"DocuTwin work orders, Trust Cards, and manual QA evidence packets.","proofRoute":"/modules/docutwin","boundary":"No PHI, record mutation, diagnosis insertion, or final note filing is authorized."},{"id":"cost-per-prior-auth","name":"Cost per prior authorization support packet","category":"unit-economics","unit":"USD per packet draft","formula":"(policy retrieval cost + document parsing cost + model drafting cost + reviewer time) / prior-auth packet drafts","targetDirection":"lower-is-better","currentMaturity":"synthetic-measurement-ready","auditSource":"Agent Workspace work orders, Atlas evidence layer, and proof packet audit.","proofRoute":"/agent-workspace","boundary":"No payer submission, coverage determination, or medical-necessity decision is authorized."},{"id":"cost-per-denial-appeal","name":"Cost per denial appeal support draft","category":"unit-economics","unit":"USD per reviewable appeal draft","formula":"(claim-context parsing + policy evidence retrieval + draft generation + qualified review allocation) / appeal-support drafts","targetDirection":"lower-is-better","currentMaturity":"synthetic-measurement-ready","auditSource":"RCM Agent work orders, TrustOS reviewer checkpoints, and governance packets.","proofRoute":"/workflows/results","boundary":"No final coding, billing, appeal submission, or reimbursement guarantee is authorized."},{"id":"time-saved-per-clinician","name":"Time saved per clinician","category":"workflow-value","unit":"minutes saved per reviewed workflow","formula":"buyer-approved baseline minutes - SCRIMED-assisted minutes for the same governed workflow","targetDirection":"higher-is-better","currentMaturity":"protected-pilot-measurement-required","auditSource":"Buyer baseline, protected pilot result packet, reviewer sign-off, and QA evidence.","proofRoute":"/pilot-evidence","boundary":"This is an operational-efficiency metric, not a clinical outcome claim."},{"id":"revenue-protected","name":"Revenue protected per payer or provider workflow","category":"workflow-value","unit":"USD at-risk revenue surfaced for qualified review","formula":"reviewed denial risk, missing-evidence exposure, or leakage opportunity identified under buyer-approved methodology","targetDirection":"higher-is-better","currentMaturity":"protected-pilot-measurement-required","auditSource":"Revenue workflow result packets, buyer finance review, and approved value methodology.","proofRoute":"/pricing","boundary":"Revenue protected is a reviewed operational signal, not a reimbursement promise or audited financial result."},{"id":"compliance-log-completeness","name":"Compliance log completeness","category":"compliance-governance","unit":"percentage of governed events with required metadata","formula":"governed events with required audit metadata / total governed events","targetDirection":"higher-is-better","currentMaturity":"synthetic-measurement-ready","auditSource":"Protected pilot audit events, TrustOS decisions, QA packets, and activation attestations.","proofRoute":"/audit","boundary":"Log completeness does not equal compliance certification or regulator acceptance."},{"id":"gross-margin-by-offer","name":"Gross margin by offer","category":"margin-discipline","unit":"percentage margin by package","formula":"(contracted package revenue - model cost - infrastructure cost - implementation labor - support allocation - reviewer allocation) / contracted package revenue","targetDirection":"within-approved-band","currentMaturity":"external-finance-review-required","auditSource":"Pricing model, sales deal room, finance review, usage logs, and delivery time tracking.","proofRoute":"/pricing","boundary":"Requires finance-reviewed cost accounting before external reporting or investor diligence use."},{"id":"model-cost-per-trust-card","name":"Model cost per Trust Card","category":"cost-control","unit":"USD per evidence-backed recommendation card","formula":"(retrieval cost + model route cost + validation cost + reviewer allocation) / Trust Cards generated","targetDirection":"lower-is-better","currentMaturity":"definition-ready","auditSource":"Atlas Trust Cards, model-router logs, validation records, and reviewer status.","proofRoute":"/atlas","boundary":"Trust Cards remain review support, not autonomous clinical decisions."}],"operatorMetricCatalog":[{"metricKey":"model-cost-usd","label":"Model cost","unit":"usd","publicMarketKpiId":"model-cost-per-trust-card","description":"Model, routing, retrieval, validation, and retry cost for a governed workflow window.","proofRoute":"/public-market-readiness","costDiscipline":"Use model routing, smaller task-specific models, retrieval-first execution, and retry budgets."},{"metricKey":"review-time-minutes","label":"Human review time","unit":"minutes","publicMarketKpiId":"time-saved-per-clinician","description":"Operator, reviewer, clinician-adjacent, or sales-engineering review minutes for a governed workflow window.","proofRoute":"/pilot-workspace/access","costDiscipline":"Track review load so SCRIMED can price human-in-the-loop safety without hiding labor cost."},{"metricKey":"delivery-hours","label":"Delivery hours","unit":"hours","publicMarketKpiId":"gross-margin-by-offer","description":"Implementation, QA, sales engineering, governance, or delivery hours spent on a scoped no-PHI workflow window.","proofRoute":"/pricing","costDiscipline":"Separate implementation services from platform license and protect enterprise gross margin."},{"metricKey":"proof-packet-count","label":"Proof packet count","unit":"count","publicMarketKpiId":"compliance-log-completeness","description":"Audited or generated proof packets released for a governed workflow window.","proofRoute":"/qa-evidence","costDiscipline":"Treat proof production as a repeatable evidence factory, not one-off consulting labor."},{"metricKey":"workflow-volume","label":"Workflow volume","unit":"count","publicMarketKpiId":"cost-per-workflow","description":"Completed synthetic, protected-pilot, or buyer-demo workflow packets in a measurement window.","proofRoute":"/workflows/results","costDiscipline":"Normalize operating cost by workflow output so SCRIMED can price against value and throughput."}],"unitEconomicsPackages":[{"packageName":"Workflow Intelligence Assessment","commercialStage":"paid assessment","priceSignal":"Starts at $50k; typical range $75k-$150k fixed fee","measurableValue":["workflow friction map","automation candidate scorecard","governance gap register","pilot success criteria"],"costDrivers":["discovery hours","workflow analysis","buyer workshops","executive findings"],"marginDiscipline":"Keep scope fixed, cap workshop hours, reuse SCRIMED assessment templates, and convert qualified accounts into higher-value pilots.","proofRoutes":["/pricing","/pilot-deal-room","/pilot"],"boundary":"Assessment output is operational intelligence, not legal, clinical, or regulatory advice."},{"packageName":"Synthetic Pilot Evaluation","commercialStage":"sellable pilot","priceSignal":"Starts at $150k; typical range $200k-$500k for 45-90 days","measurableValue":["cost per governed workflow","time saved estimate","workflow friction reduced","Trust Card completeness","production-readiness gates"],"costDrivers":["agent runs","synthetic workflow design","proof packets","review meetings","QA evidence"],"marginDiscipline":"Use task-specific agents, deterministic synthetic fixtures, bounded model routes, and reusable governance packets.","proofRoutes":["/product","/evaluation","/qa-evidence","/demos"],"boundary":"Synthetic data only; no PHI, diagnosis, payer submission, patient outreach, or live execution."},{"packageName":"Protected Enterprise Pilot","commercialStage":"protected pilot","priceSignal":"Starts at $750k; typical range $1M-$2.5M for 90-180 days","measurableValue":["buyer-approved workflow baseline","reviewer acceptance rate","override and escalation rates","cost per work order","readiness gates closed"],"costDrivers":["tenant setup","identity controls","human review","security diligence","governance operations"],"marginDiscipline":"Charge separately for connectors, implementation, evidence vault controls, custom support, and regional compliance work.","proofRoutes":["/pilot-workspace/access","/clinical-care-activation","/trust-safety-operations"],"boundary":"Protected pilot does not authorize live clinical execution until external approvals and customer-specific controls pass."},{"packageName":"Enterprise Operating License","commercialStage":"annual platform license","priceSignal":"Annual platform license starts at $2.5M; enterprise range $3M-$12M+","measurableValue":["workflows under governance","departments served","model cost per workflow","audit completeness","expansion revenue"],"costDrivers":["platform support","workflow count","connectors","monitoring","customer success"],"marginDiscipline":"Separate platform license from implementation services and charge add-ons for workflow, connector, region, and support expansion.","proofRoutes":["/pricing","/observability","/deployment-profiles"],"boundary":"Production terms require signed scope, security review, privacy controls, and human-review operating procedures."}],"modelEfficiencyControls":[{"control":"Task-specific agent routing","operatingPolicy":"Route narrow workflow tasks to specialized agents instead of a single large general-purpose agent.","costControl":"Use deterministic preprocessing, small-model classification, and retrieval-before-generation before escalating to premium models.","safetyControl":"Escalate uncertainty and high-risk clinical-adjacent content to human review.","proofRoute":"/agents"},{"control":"Open and closed model optionality","operatingPolicy":"Keep model-provider abstraction so SCRIMED can route between frontier APIs, healthcare-specific models, open-weight models, and future sovereign deployments.","costControl":"Choose the least expensive route that satisfies safety, latency, context, and evidence requirements.","safetyControl":"Do not route PHI-sensitive or regulated tasks without approved deployment controls.","proofRoute":"/healthcare-intelligence-os"},{"control":"Token and evidence budgets","operatingPolicy":"Attach workflow-level budgets for context size, evidence retrieval depth, model calls, retries, and reviewer effort.","costControl":"Track cost per workflow, Trust Card, chart, prior-auth packet, and denial draft.","safetyControl":"Block budget-driven shortcuts that remove citations, confidence, or review gates.","proofRoute":"/observability"},{"control":"Workflow-owned data loops","operatingPolicy":"Optimize around customer workflow outcomes rather than generic benchmark scores.","costControl":"Invest in reusable workflow traces, corrections, and governance packets that improve future runs without retraining foundation models.","safetyControl":"Use deidentified or synthetic feedback until privacy and customer data rights are approved.","proofRoute":"/pilot-evidence"}],"complianceLogs":[{"log":"Protected pilot audit events","owner":"TrustOS, engineering, and tenant admins","currentSource":"Tenant-scoped Supabase audit events and proof-packet release logs.","proofRoute":"/pilot-workspace/access","metricUse":"Compliance log completeness, customer proof, and buyer diligence.","boundary":"No PHI, secrets, or live medical records are stored in current protected packets."},{"log":"QA evidence ledger","owner":"Engineering and trust operations","currentSource":"Dated smoke, build, manual-run, and no-secret QA evidence.","proofRoute":"/qa-evidence","metricUse":"Release discipline, defect visibility, and investor diligence.","boundary":"QA evidence is product reliability evidence, not certification."},{"log":"Clinical activation dossier and approvals","owner":"Clinical governance, legal, security, privacy, and operations","currentSource":"No-PHI AAL2 clinical activation readiness attestations and packets.","proofRoute":"/clinical-care-activation","metricUse":"Hard-gate closure, readiness posture, and regulated deployment planning.","boundary":"Readiness attestations do not authorize live clinical care."},{"log":"Buyer diligence and secure evidence vault readiness","owner":"Sales operations, legal, privacy, and security","currentSource":"Buyer room, diligence packets, and disabled-by-default vault readiness controls.","proofRoute":"/pilot-deal-room","metricUse":"Customer proof, revenue-stage maturity, and enterprise procurement readiness.","boundary":"Sensitive buyer document storage remains disabled until approved controls exist."},{"log":"Protected operator metric ledger","owner":"Founder, finance advisor, product, and trust operations","currentSource":"AAL2 tenant-scoped no-PHI captures for model cost, review time, delivery hours, proof-packet count, and workflow volume.","proofRoute":"/pilot-workspace/access","metricUse":"Unit-economics discipline, board review, pricing posture, and finance-readiness coverage.","boundary":"Operator metrics are aggregate operating metadata, not audited financial reporting, securities offering material, valuation assurance, reimbursement assurance, or clinical validation."},{"log":"Trust Safety Operations","owner":"Trust, safety, legal, security, communications, and executive leadership","currentSource":"Incident, copyright, public-claims, safety, escalation, and continuous-improvement registers.","proofRoute":"/trust-safety-operations","metricUse":"Public-company operating discipline and brand-risk control.","boundary":"Current registers do not replace managed 24/7 SOC, counsel review, or insurance decisions."}],"customerProofStages":[{"stage":"Public product proof","buyerCommitment":"Self-guided inspection","scrimedProof":"Product console, demos, pricing, Trust Center, and public market readiness.","revenueSignal":"Qualified buyer enters pilot intake or sales conversation.","nextGate":"Paid assessment scope and no-PHI acknowledgement."},{"stage":"Paid assessment","buyerCommitment":"Fixed-fee workflow intelligence engagement","scrimedProof":"Workflow maps, governance gap register, KPI baseline plan, and pilot recommendation.","revenueSignal":"Assessment revenue plus qualified pilot conversion.","nextGate":"Synthetic pilot success criteria and sponsor approval."},{"stage":"Synthetic pilot","buyerCommitment":"45-90 day governed evaluation","scrimedProof":"Synthetic workflow packets, Trust Cards, QA evidence, observability, and buyer diligence export.","revenueSignal":"Pilot revenue and expansion case.","nextGate":"Protected pilot data boundary, security, legal, privacy, and identity approvals."},{"stage":"Protected enterprise pilot","buyerCommitment":"Tenant-isolated governed pilot","scrimedProof":"AAL2 access, audit events, approval workflow, command intelligence, and proof packets.","revenueSignal":"Protected pilot revenue and enterprise license proposal.","nextGate":"Signed production controls, human-review SOP, connector validation, and go-live approval."},{"stage":"Enterprise operating license","buyerCommitment":"Annual or multi-year platform agreement","scrimedProof":"Measured workflow value, margin discipline, governance reporting, and expansion roadmap.","revenueSignal":"Recurring platform revenue, modules, connectors, regions, and support expansion.","nextGate":"Board-level value review and multi-workflow expansion."}],"boardCadence":[{"cadence":"Weekly operating review","owner":"Founder, product, engineering, sales, and trust operations","reviewedSignals":["build and smoke status","protected route failures","sales intake quality","buyer proof packet readiness","known blockers"],"decisionOutput":"fix list, release gate, buyer follow-up, and next build step"},{"cadence":"Monthly metric review","owner":"Founder, finance advisor, sales, product, and delivery","reviewedSignals":["cost per workflow","pilot conversion","time saved signal","model cost trend","delivery effort by package"],"decisionOutput":"pricing adjustments, margin guardrails, and pilot scope standards"},{"cadence":"Quarterly governance review","owner":"Executive leadership, counsel, security, privacy, clinical advisors, and board advisors","reviewedSignals":["claims register","clinical activation gates","security/privacy blockers","incident trends","enterprise-readiness gaps"],"decisionOutput":"approved claims, prohibited claims, risk acceptances, and production readiness decisions"},{"cadence":"Investor diligence review","owner":"Founder, finance, legal, product, and investor relations","reviewedSignals":["customer proof ladder","unit economics maturity","gross margin assumptions","recurring revenue path","competitive edge"],"decisionOutput":"board memo, investor packet, and external-review queue"}],"limitations":[{"limitation":"No audited financial statements inside SCRIMED yet","impact":"External investors cannot treat current KPI stack as audited financial reporting.","workaround":"Use the KPI definitions, pricing tiers, sales audit evidence, and proof packets as operating-readiness material while finance and accounting review is completed.","graduationGate":"Finance-reviewed chart of accounts, revenue recognition policy, cost allocation, and audit-ready reporting."},{"limitation":"No live clinical outcomes","impact":"SCRIMED cannot claim patient-outcome improvement from production deployment.","workaround":"Report synthetic and protected-pilot operational metrics only, then graduate to customer-approved outcome studies after legal, clinical, privacy, and data rights approval.","graduationGate":"Customer-approved clinical governance protocol, IRB or ethics review when required, and signed data-processing path."},{"limitation":"No PHI-enabled cost telemetry","impact":"Patient-level cost per interaction remains a pilot-equivalent definition.","workaround":"Use synthetic interactions and buyer-approved aggregate workflow baselines until PHI authorization, BAA/DPA, consent, and production controls exist.","graduationGate":"Approved production data boundary, minimum-necessary design, audit controls, and customer authorization."},{"limitation":"No securities offering or valuation guarantee","impact":"Investor narrative must stay as strategic positioning, not investment solicitation.","workaround":"Keep public-market readiness language framed as internal operating discipline and diligence preparation, with counsel-reviewed materials before fundraising use.","graduationGate":"Qualified securities counsel, approved investor materials, and controlled data-room process."},{"limitation":"Secure evidence vault storage remains disabled by default","impact":"Sensitive buyer diligence artifacts cannot be uploaded into SCRIMED yet.","workaround":"Use metadata-only vault readiness and buyer-approved external secure channels until DLP, malware scanning, encryption, retention, legal hold, and access reviews are approved.","graduationGate":"Approved storage provider, security controls, legal terms, incident response, and access-review workflow."}],"nextBuildStep":"Add customer-ready security questionnaire response registry and procurement evidence routing without storing confidential questionnaires, SOC reports, penetration-test reports, credentials, PHI, signed legal artifacts, or sensitive customer documents in SCRIMED.","updated":"2026-06-20"},"salesDealRoomSummary":{"service":"scrimed-sales-deal-room","route":"/pilot-deal-room","apiRoute":"/api/pilot-deal-room","protectedPacketRoute":"/api/sales-operations/opportunities/{intakeId}/deal-room-packet","workspaceProvisioningRoute":"/api/sales-operations/opportunities/{intakeId}/workspace-provisioning","workspaceProvisioningPacketRoute":"/api/sales-operations/opportunities/{intakeId}/workspace-provisioning/packet","buyerTenantLifecycleRoute":"/api/sales-operations/opportunities/{intakeId}/tenant-lifecycle","buyerTenantLifecyclePacketRoute":"/api/sales-operations/opportunities/{intakeId}/tenant-lifecycle/packet","productionActivationReadinessRoute":"/api/sales-operations/opportunities/{intakeId}/production-readiness","productionActivationReadinessPacketRoute":"/api/sales-operations/opportunities/{intakeId}/production-readiness/packet","customerActivationApprovalsRoute":"/api/sales-operations/opportunities/{intakeId}/activation-approvals","customerActivationApprovalsPacketRoute":"/api/sales-operations/opportunities/{intakeId}/activation-approvals/packet","buyerDiligenceRoomRoute":"/api/sales-operations/opportunities/{intakeId}/buyer-diligence","buyerDiligenceRoomPacketRoute":"/api/sales-operations/opportunities/{intakeId}/buyer-diligence/packet","secureEvidenceVaultReadinessRoute":"/api/sales-operations/opportunities/{intakeId}/evidence-vault-readiness","secureEvidenceVaultReadinessPacketRoute":"/api/sales-operations/opportunities/{intakeId}/evidence-vault-readiness/packet","status":"public-organization-and-protected-packet-ready","defaultWorkspaceSlug":"atlas-synthetic-evaluation","proofStackStatus":"sales-to-buyer-room-linkage-ready","buyerRoomProofStackStatus":"aal2-buyer-room-evidence-bundle","buyerRoomPacketProofStackStatus":"aal2-audited-buyer-diligence-export","opportunityWorkspaceProvisioningProofStackStatus":"aal2-opportunity-workspace-provisioning","opportunityWorkspaceProvisioningPacketProofStackStatus":"aal2-audited-opportunity-workspace-packets","buyerTenantLifecycleProofStackStatus":"aal2-buyer-tenant-lifecycle-automation","buyerTenantLifecyclePacketProofStackStatus":"aal2-audited-buyer-tenant-lifecycle-packets","productionActivationReadinessProofStackStatus":"aal2-production-sso-invitation-readiness","productionActivationReadinessPacketProofStackStatus":"aal2-audited-production-readiness-packets","customerActivationApprovalsProofStackStatus":"aal2-paid-pilot-activation-approvals","customerActivationApprovalsPacketProofStackStatus":"aal2-audited-activation-approval-packets","buyerDiligenceRoomProofStackStatus":"aal2-buyer-evidence-signed-controls-diligence-room","buyerDiligenceRoomPacketProofStackStatus":"aal2-audited-buyer-diligence-packets","secureEvidenceVaultReadinessProofStackStatus":"aal2-secure-evidence-vault-readiness-disabled-by-default","secureEvidenceVaultReadinessPacketProofStackStatus":"aal2-audited-secure-evidence-vault-readiness-packets","executiveThesis":"SCRIMED converts public product proof, governed pilot intake, tenant-admin sales operations, buyer-room diligence, premium pricing, and protected workspace evidence into one enterprise-ready pilot acquisition path.","stages":[{"stage":"1. Discover","buyerQuestion":"What is SCRIMED and why is it differentiated?","scrimedProof":"Official website, competitive edge page, Product Console, Trust Center, and pricing posture.","primaryRoute":"/competitive-edge","gatedBoundary":"Public education only; no buyer data or clinical claims required."},{"stage":"2. Evaluate","buyerQuestion":"Can the product show governed workflow value before live data?","scrimedProof":"Demos, AgentOS evaluation, workflows, synthetic fixtures, Trust Cards, and proof routes.","primaryRoute":"/demos","gatedBoundary":"Synthetic scenarios only; no PHI or patient-facing execution."},{"stage":"3. Request","buyerQuestion":"Can my organization scope a paid assessment or synthetic pilot?","scrimedProof":"Pilot intake captures buyer segment, workflow targets, governance needs, and no-PHI acknowledgement.","primaryRoute":"/pilot","gatedBoundary":"Business-contact and workflow-scope intake only."},{"stage":"4. Qualify","buyerQuestion":"Can SCRIMED manage opportunity ownership and next steps?","scrimedProof":"Sales Operations provides tenant-admin ownership, pipeline stage, follow-up, assessment scheduling, and audit.","primaryRoute":"/sales-operations","gatedBoundary":"AAL2 tenant-admin access required; no direct table mutation."},{"stage":"5. Prove","buyerQuestion":"Can we inspect tenant-scoped proof and limitations before paying for more scope?","scrimedProof":"Buyer Pilot Room bundles readiness, evidence counts, commercial path, competitive edge, limitations, and packet audit.","primaryRoute":"/pilot-workspace/access","gatedBoundary":"Protected tenant workspace; synthetic-only, write-before-release artifacts."},{"stage":"6. Commit","buyerQuestion":"What commercial step should we approve next?","scrimedProof":"Non-binding deal-room packet, proposal, pricing tier, governance pack, and buyer-specific next action.","primaryRoute":"/pricing","gatedBoundary":"Final scope, legal terms, security review, and production permissions require written approval."}],"siteLanes":[{"lane":"Official Website","audience":"Public buyers, partners, advisors, and press","route":"https://www.scrimedsolutions.com","purpose":"Brand credibility, founder story, broad education, and top-of-funnel trust.","handoff":"Route serious buyers to the product app, pilot intake, or competitive-edge page."},{"lane":"Product App","audience":"Enterprise evaluators, investors, and sales engineering","route":"https://app.scrimedsolutions.com","purpose":"Show the actual SCRIMED product console, demos, pricing, trust posture, workflows, and protected pilot access.","handoff":"Move from self-guided proof to a paid assessment or synthetic pilot."},{"lane":"Protected Workspace","audience":"Approved tenant admins, pilot leads, reviewers, and SCRIMED operators","route":"/pilot-workspace/access","purpose":"Package tenant-scoped synthetic sessions, audit evidence, demo readiness, TrustOps, and Buyer Diligence Exports.","handoff":"Use audited packets for diligence follow-up and protected-pilot planning."},{"lane":"Sales Operations","audience":"SCRIMED tenant-admin commercial operators","route":"/sales-operations","purpose":"Own opportunities, proposals, follow-ups, CRM export, attribution packets, assessment invites, and deal-room packets.","handoff":"Create a buyer-specific packet that links opportunity scope to product proof and the protected Buyer Pilot Room."}],"competitiveEdges":[{"pillar":"Healthcare Intelligence Infrastructure","claim":"SCRIMED is positioned as a governed healthcare intelligence operating layer, not another chatbot, ambient note feature, or isolated automation tool.","proof":"AgentOS, Atlas Intelligence Core, TrustOS, persistent workspaces, interoperability contracts, and audit packets are exposed as one operating stack.","route":"/healthcare-intelligence-os","blockedClaim":"Does not claim autonomous clinical execution or replacement of healthcare professionals."},{"pillar":"Trust-First Enterprise Proof","claim":"Every buyer-facing proof artifact is designed around human review, tenant isolation, synthetic-only boundaries, and write-before-release audit evidence.","proof":"Protected pilot workspaces use Supabase Auth, AAL2 assurance, tenant-scoped RLS, durable sessions, audit events, demo snapshots, and proof packets.","route":"/pilot-workspace/access","blockedClaim":"Does not claim HIPAA certification, SOC 2 certification, FDA clearance, or production authorization."},{"pillar":"Interoperability Sidecar Strategy","claim":"SCRIMED can sit beside existing EHR, payer, imaging, device, and analytics systems as a review-gated intelligence layer instead of replacing the record of truth.","proof":"FHIR, HL7 v2, DICOM/DICOMweb, X12, C-CDA, LOINC, SNOMED CT, RxNorm, ICD, and CPT/HCPCS readiness are represented through synthetic contracts and conformance routes.","route":"/interoperability","blockedClaim":"Does not claim certified live connector status or production EHR writeback during synthetic pilots."},{"pillar":"Evidence-To-Revenue Motion","claim":"SCRIMED sells high-value enterprise evaluation, protected pilots, and operating licenses anchored to workflow value, governance scope, and measurable proof.","proof":"Pricing tiers, pilot intake, Sales Operations, attribution analytics, enterprise proof packets, and the Buyer Diligence Export connect product evidence to commercial execution.","route":"/pricing","blockedClaim":"Does not guarantee savings, reimbursement, denial reduction, or clinical outcomes."},{"pillar":"FaithCore And Atlas Trust Positioning","claim":"SCRIMED can serve enterprise-neutral buyers through Atlas while preserving a distinct spiritually aligned FaithCore pathway for organizations that explicitly want it.","proof":"FaithCore and Atlas remain separate positioning lanes, keeping enterprise compliance language professional while allowing faith-aligned encouragement where appropriate.","route":"/faithcore","blockedClaim":"Does not mix spiritual support with diagnosis, treatment, emergency triage, or clinical authority."},{"pillar":"Global Deployment Optionality","claim":"SCRIMED is being shaped for cloud, private cloud, sovereign cloud, hospital-controlled, and edge/on-prem evaluation paths.","proof":"Deployment profiles, strategic platform intelligence, runtime safety gates, and no-live-data synthetic evaluations preserve buyer optionality before production scope.","route":"/deployment-profiles","blockedClaim":"Does not claim region-specific compliance approval until legal, privacy, security, and customer deployment review are complete."}],"limitations":[{"limitation":"Opportunities now support buyer-specific protected workspace provisioning and lifecycle activation after qualification.","resolution":"Qualified opportunities can provision a protected workspace, activate buyer tenant lifecycle controls, package domain SSO policy, manual invitation delivery, access review cadence, retention/archive controls, and audited packets. Unprovisioned opportunities still route to the default synthetic workspace with clear labeling.","productionGate":"Signed customer tenant architecture, production SSO configuration, transactional email approval, legal review, and live connector authorization."},{"limitation":"Production SSO, automated invitations, and workspace archive execution still require customer-specific approval.","resolution":"Production readiness packets now package buyer-domain verification, redirect/origin registry, invitation template approval, transactional delivery guardrails, access-review attestation, and archive runbook before any automated send or SSO cutover.","productionGate":"Verified buyer domain, approved IdP configuration, approved sending provider, legal/privacy/security sign-off, incident response path, and written enterprise authorization."},{"limitation":"Written SCRIMED approval can unblock paid pilot setup, but not live healthcare operations.","resolution":"Customer activation approval packets now record paid-pilot setup authorization, allowed setup actions, retained blockers, owner approvals, and evidence requirements after production readiness exists.","productionGate":"Separate buyer and SCRIMED written approval for PHI, production connectors, customer SSO cutover, automated bulk invitations, payer submission, patient outreach, clinical validation, and live workflow execution."},{"limitation":"Sensitive buyer diligence documents should not be uploaded until storage, DLP, retention, and legal hold controls are approved.","resolution":"Buyer diligence rooms now track metadata-only evidence requirements, signed-control status, BAA/DPA posture, IdP/domain proof needs, transactional provider decisions, production connector readiness, and packet history without collecting sensitive files.","productionGate":"Approved document storage, malware scanning, DLP, retention/legal hold, access reviews, buyer-approved secure exchange path, and counsel-reviewed signed controls."},{"limitation":"Sensitive evidence vaulting is not enabled until security, privacy, legal, residency, and incident controls are approved.","resolution":"Secure evidence vault readiness now packages disabled-by-default storage-provider decisioning, encryption/key management, DLP, malware scanning, retention/legal hold, access reviews, evidence classification, upload approval, incident response, regional residency, target audience, and revenue-path controls.","productionGate":"Approved vault provider, BAA/DPA path, encryption key ownership, DLP/malware controls, legal hold, deletion workflow, access review cadence, incident response, region policy, counsel review, and buyer authorization."},{"limitation":"Authenticated happy-path automation still requires a short-lived AAL2 bearer token.","resolution":"Keep fail-closed public smoke checks and use human AAL2 browser sessions for buyer packet generation.","productionGate":"Approved CI secret rotation, token expiry, and identity operations."},{"limitation":"Direct live connectors, PHI workflows, payer submission, and patient outreach remain blocked.","resolution":"Use synthetic fixtures, contracts, conformance evidence, and human-reviewed proof packets until production scope is signed.","productionGate":"Legal, privacy, security, clinical governance, BAA/DPA path, and connector validation."}],"boundary":"SCRIMED Pilot Deal Rooms organize public product proof, tenant-admin sales evidence, buyer-room routing, pricing posture, and non-binding proposal artifacts for governed synthetic evaluations only. They do not accept PHI, authorize live clinical execution, certify compliance, guarantee reimbursement, submit payer transactions, or provide medical, legal, or regulatory advice.","updated":"2026-06-17"},"updated":"2026-06-24"}